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Executive summary 
The issue of NHS productivity currently holds substantial public attention, particularly given the 
efficiency challenge set out in the Five Year Forward View published by NHS England and other 
national bodies 2014.  In 2015 the Department of Health appointed a Minister (Parliamentary under 
Secretary of State) with a specific ministerial brief for NHS productivity. 
 
This report is the latest in a regular series of NHS productivity measures produced by the Centre for 
Health Economics.  This report updates the time-series of National Health Service (NHS) productivity 
to account for growth between 2012/13 and 2013/14.  NHS output encompasses all activity, as 
valued by administrative costs, for NHS patients, and is measured by combining data from Reference 
Costs, Hospital Episode Statistics, Prescription Cost Analysis, and the GP Patient Survey. 
 
NHS inputs are made up of labour, intermediates and capital, used by the NHS in carrying out its 
activity for the financial year.  We calculate input growth using data from organisational accounts 
and from workforce data.  
 
Productivity growth is positive when the rate of growth of outputs exceeds that of inputs  W as we 
again observe here for the most recent financial year  W and negative when the opposite is true. 
 
Output growth is measured at 2.64% for the NHS as a whole, with improvements in quality 
accounting for 0.27% of this growth.  dŚĞƐĞƌĂƚĞƐƌĞƉƌĞƐĞŶƚĂŶŝŶĐƌĞĂƐĞŽŶƚŚĞƉƌĞǀŝŽƵƐǇĞĂƌ ?Ɛ
output growth of 2.34%  W the lowest recorded since our series began in 2004/5  W and a return to a 
positive quality adjustment.  Quality improvements include reductions in waiting times and 
improvements in HRG-level survival rates following discharge from hospitals.  Output growth is 
broadly within the range observed over the last four years, and is driven mainly by growth in non-
admitted activity as captured by Reference Cost data.   
 
We find that overall NHS input growth is low, at around 0.55%, and down from 2.36% on the 
previous year.  This is mainly due to replacement of Primary Care Trusts by Clinical Commissioning 
Groups, following the 2012 Health & Social Care Act. 
 
Productivity growth between 2012/13 and 2013/14 for the NHS was 2.07%.  This represents a 
substantial rise on the 0.36% estimate recorded for the previous financial year, and is the fourth 
consecutive period of positive year-on-year productivity growth. 
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Glossary of acronyms 
A&E Accident & Emergency 
AD Admitted 
ALB Arm's Length Body 
CCG Clinical Commissioning Group 
CDEL Capital Departmental Expenditure Limit 
CIPS Continuous Inpatient Spell 
CQC Care Quality Commission 
CSU Commissioning Support Unit 
DH Department of Health 
ESR Electronic Staff Record 
FCE Finished Consultant Episode 
FTE Full-time Equivalent 
H&SC Act Health & Social Care Act 2012 
HES Hospital Episode Statistics 
HRG(4/4+) Healthcare Resource Group (version 4/4+) 
HSCIC Health and Social Care Information Centre 
ISHP Independent Sector Health Care Provider 
MH Mental Health 
MSG Major Staff Group 
NAD Not admitted 
NHS National Health Service 
ONS Office for National Statistics 
PCA Prescription Cost Analysis 
PCT Primary Care Trust 
PSSRU Personal & Social Services Research Unit 
QOF Quality and Outcomes Framework 
RC Reference Costs 
RDEL Revenue Departmental Expenditure Limit 
RDNA Regular Day and Night Attendance 
SHA Strategic Health Authority 
SUS Secondary Uses Service 
TDEL Total Departmental Expenditure Limit 
TFR Trust Financial Returns 
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1. Introduction 
In this report we calculate growth in NHS productivity between 2012/13 and 2013/14, thereby 
extending our series that provides estimates of growth from 1998/99 onwards.  The series was first 
published in 2004/05.   
 
Arguably, interest in NHS productivity has never been higher.  The publication of the Five Year 
Forward View by NHS England presents the view that despite a budget for the NHS of approximately 
£110bn per annum (DH Annual Report and Accounts 2013-14), increasing demand created by an 
ageing population and changes in public expectation means that the NHS could struggle to meet the 
healthcare needs of the population it serves: it is estimated that without an even greater increase in 
real inputs or further efficiency savings, the NHS will face a funding gap of some £30bn by 2020/21
1
.  
Subsequent commitments to additional financing would in effect narrow this gap to £22bn.   
 
We have previously calculated that, prior to 2013/14, growth in ƚŚĞŶŐůŝƐŚE,^ ?ƐƉƌŽĚƵĐƚŝǀŝƚǇŚĂƐ
been consistently positive over 3 pairs of years  W an unprecedented run of positive productivity 
growth (Bojke et al., 2015).  We have attributed this result to a sustained period of restrained input 
growth (in particular, labour input growth).  Output growth in recent years has also been below 
earlier trends, but has not fallen as far as input growth below its respective trend. 
 
The financial year 2013/14 not only represents the fifth year of the longest period of austerity the 
E,^ŚĂƐŬŶŽǁŶ ?ƚŚĞƚŚŝƌĚǇĞĂƌŽĨƚŚĞŽƌŝŐŝŶĂůĨŽƵƌǇĞĂƌ ‘EŝĐŽůƐŽŶŚĂůůĞŶŐĞ ?2, but also the first year 
in which the NHS reforms established by the Health & Social Care Act 2012 (H&SC Act) came into 
force.  The H&SC Act may have had two important impacts on productivity.  Firstly, it may have 
directly affected the productivity of the NHS itself.  But secondly, and perhaps less obviously, the 
large scale reorganisation may also have impacted on the collection and coverage of the large-scale 
routine datasets used to measure the inputs and outputs of the NHS.  For example, although PCTs 
existed until the end of the 2012/13 financial year, they were not required to contribute to 2012/13 
Reference Costs.  This means that there is some risk that aspects of both inputs and outputs may not 
have been captured in a consistent way across the two years.   
 
Similarly, it is not clear to what extent many of the new organisations (such as the newly created 
Clinical Commissioning Groups (CCGs)) have fully contributed to both input and output data sources.  
For example only 70% of CCGs provide centralised labour force data and none provide output data 
to Reference Costs, although it is clear from other sources, such as the Hospital Episode Statistics, 
that CCGs provide at least some outpatient activity.  This means that the ability to calculate growth 
across the whole NHS is somewhat compromised. 
 
The other major change between 2012/13 and 2013/14 that might impact on productivity is the 
consequence of the publication of various reports, all of which made staffing recommendations: the 
Francis Inquiry (Francis R. (Chair), 2010), the Keogh Review (Keogh, 2013), the Berwick Review 
(Berwick, 2013) and the new regulatory regime for the Care Quality Commission (CQC).  All these 
reviews suggested that there were quality and safety consequences to understaffing or 
inappropriate staffing mixes.  These reports are argued to have led to a recruitment drive and 
increase in staffing in the latter half of 2013/14 (Appleby J. et al, 2014). 
 
As with our previous reports, we follow national accounting conventions to measure the change in 
productivity over time by means of a chained index (Eurostat, 2001).  We concentrate on the 
calculation and comparison of output and inputs between 2012/13 and 2013/14. ThŝƐůĂƚĞƐƚ ‘ůŝŶŬ ? is 
                                                          
1
 https://www.england.nhs.uk/wp-content/uploads/2014/10/5yfv-web.pdf 
2
 More formally known as the Quality, Innovation, Productivity and Prevention (QIPP) programme 
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then attached to the chained index that reports productivity changes over the entire period from 
2004/5.  
 
The methods we adopt are unchanged from previous reports and so we relegate the detail of 
formulating the indices to a technical appendix, but provide a brief summary here.  In our output 
calculations, we construct a Laspeyres volume growth index.  In the continued absence of 
comprehensive health outcome data, we weight different types of NHS output using the previous 
ǇĞĂƌ ?ƐĐŽƐƚĨŽƌeach specific output.  We also quality-adjust the cost-weighted output to take into 
account changes in 30-day survival following discharge from hospital, waiting times, and 
improvements in blood pressure monitoring in primary care.  Thus, all other things being equal, 
improved quality in these dimensions contributes to productivity growth. 
 
Growth in the volume of inputs is calculated primarily using accounts data.  Current spending on 
ůĂďŽƵƌ ?ĐĂƉŝƚĂůĂŶĚŝŶƚĞƌŵĞĚŝĂƚĞƌĞƐŽƵƌĐĞƐĂƌĞĚĞĨůĂƚĞĚƚŽůĂƐƚǇĞĂƌ ?ƐĐŽƐƚƐŝŶŽƌĚĞƌƚŽĨĂĐŝůŝƚĂƚĞĂ
meaningful comparison of the volume of input use in the paired years.  In the case of labour, a more 
direct measure is possible for the majority of organisations because information about the volume 
and costs of staff is available from the NHS Electronic Staff Record (ESR).  This permits two 
alternative measures of input growth  W one constructed entirely from deflated accounts data (the 
indirect measure) and one which uses indirect measures of capital and intermediates but the direct 
measure of labour growth where  possible (the mixed measure of input growth).  This allows us to 
assess how sensitive productivity growth is to how labour input is measured. 
 
The focus of the report is on the data used to calculate output and input growth between 2012/13 
and 2013/14.  Specific details are provided about any potential artefacts that may compromise a 
genuine like-for-like comparison across the two years. 
 
The structure of the report is as follows.  In Section 2 we describe changes to the NHS that are likely 
to impact on productivity measurement over this period.  The output index is populated in Section 3, 
and the elements of the input index are reported in Section 4.  Section 5 reports the productivity 
growth figures.  Summary and concluding remarks are provided in Section 6. 
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2. Organisational change in the NHS, money flows and productivity coverage 
The H&SC Act 2012 introduced major changes to the underlying commissioning structure of the NHS.  
As Figure 1 shows, ŶŐůĂŶĚ ?Ɛ ? ?^ƚƌĂƚĞŐŝĐ,ĞĂůƚŚƵƚŚŽƌŝƚŝĞƐ ?^,Ɛ )ĂŶĚ ? ? ?WƌŝŵĂƌǇĂƌĞdƌƵƐƚƐ
(PCTs) were abolished and their combined functions replaced by a new structure: NHS England, 
incorporating 4 Regional Offices, 27 Area Teams, 17 Commissioning Support Units (CSUs) and 211 
Clinical Commissioning Groups (CCGs).  In addition, the creation of new non-NHS ƌŵ ?Ɛ>ĞŶŐƚŚ 
Bodies (ALBs), such as Public Health England, has changed the overall role of the Department of 
Health (DH) itself.  Changes to the provider landscape have been less marked.  Between 2012/13 and 
2013/14, only a small number of trusts merged, changed from NHS to Foundation Trusts, or were 
dissolved.  
 
 
Figure 1 : Organisational change in the NHS 
 
 
 
Figure 2 : Activity coverage in 2013/14 
 
This organisational restructuring has consequences for defining the scope of the productivity 
measure: the objective of this report is to cover the growth of the inputs and outputs related to NHS 
England.  A comparison of like-for-like which includes DH spending is problematic because it is not 
possible to attribute the distribution of DH input across its multiple functions with ALBs.  As a result, 
the 2012/13 to 2013/14 productivity measure is limited to the organisations in Figure 1 below the 
DH or, equivalently, those in the shaded boxes in Figure 2. 
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Although we do not use top-line accounts data as our measures of inputs, it is useful to have a broad 
understanding of the revenue flows in order to place the productivity components and measures in 
context.  According to national accounts, the DH had a Revenue Departmental Expenditure Limit 
(RDEL) outturn of £106bn in 2013/14  W an increase from £103bn in 2012/13.  Of this, £95bn was 
allocated to NHS England.  A further £4.3bn of DH Capital DEL was spent in 2013/14 compared to 
3.8bn in 2012/13.  This sums to a total DH spend of approximately £110bn in 2013/14, compared to 
£107bn in 2012/13 (DH Annual Report and Accounts 2013-14).  
 
NHS England accounts (2014) report RDEL spend for the NHS England Group (NHS England plus CSUs 
and CCGs) of some £94.5bn for 2013/14.  An equivalent top-line figure for 2012/13 is difficult to 
construct as there was no single organisation responsible for that slice of inputs below the DH, and 
hence no single definitive source of accounts data.  However, DH annual accounts (2013) report a 
combined RDEL outrun of £98.8bn to SHA/PCTs and providers in 2012/13.  The perceived drop in the 
RDEL spend between 2012/13 and 2013/14 is likely due to the reporting artifact resulting from the 
organisational changes in the NHS.  
 
Approximately two-thirds of this budget is allocated (in 2013/14 to CCGs) for locally commissioned 
services such as: secondary care, community services, mental health services and rehabilitation 
services.  The remaining third is spent by NHS England directly on running costs and nationally 
commissioned services including primary care and many specialised services.  In 2012/13 
approximately 80% was allocated to PCTs to cover primary and secondary healthcare purchases.   
 
Some of the nationally commissioned services by NHS England are purchased from provider trusts, 
thus approximately 75% of its total budget is for secondary care expenditure.  In 2013/14, some 
£10bn of this was in non-NHS organisations.  DH account figures suggest that spending on primary 
care amounts to around 22% of TDEL expenditure. 
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3. Output 
3.1 Measuring output 
Our NHS output index is designed to capture all activities provided to NHS patients, whether by NHS 
or private sector organisations.  Table 1 below summarises data sources used to measure activity, 
quality and costs, and also indicates specific measurement issues that have had to be tackled in 
constructing the output growth index for 2012/13  W 2013/14.  The data and these specific issues are 
detailed in the remainder of this section.  It should be noted that we have two alternative sources of 
volume of activity for outpatient output: the Hospital Episode Statistics (HES) outpatient dataset, 
and the Reference Costs database.  We compare the outpatient activity in these datasets. 
 
Table 1 Summary of output data sources 
Output type Activity source Cost source Quality Notes for 2012/13 and 2013/14 
data 
Elective HES RC 30-day survival;  
health 
outcomes; 
waiting times 
Activity described by HRG4+ 
     
Non-elective HES RC 30-day survival; 
health 
outcomes 
 Activity described by HRG4+ 
     
Outpatient HES (or RC)  RC Waiting times Waiting time comes from HES 
Two sources of activity data 
     
Mental health HES & RC RC 30-day survival;  
health 
outcomes; 
waiting times 
Due to error in the reporting by 
one trust,  the data used does 
not match the online Reference 
Cost data 
     
Community care RC RC N/A  
     
A&E RC RC N/A  
     
Other (1) RC RC N/A  
     
Primary care Pre-2009/10 
from QResearch 
Post-2009/10 
from GP patient 
survey 
PSSRU Unit 
Costs of Health 
and Social Care 
QOF data Uplift survey responses by 
population growth; changes in 
QOF data 
     
Prescribing Prescription 
cost analysis 
system 
Prescription 
cost analysis 
system 
N/A  
     
Ophthalmic and 
dental services 
HSCIC HSCIC N/A  
Glossary HES: Hospital Episode Statistics; RC: Reference Costs; HRG4+: Healthcare Resource Groups version 4+; 
MH: Mental Health; PSSRU: Personal & Social Services Research Unit; QOF: Quality and Outcomes 
Framework; DH: Department of Health; HSCIC: Health and Social Care Information Centre 
Note (1) Radiotherapy & High Cost Drugs, Diagnostic Tests, Hospital/patient Transport Scheme, Radiology, 
Rehabilitation, Renal Dialysis, Specialist Services 
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3.2 HES inpatient, day case, outpatient and mental health data 
HES is the source of data for both the amount of activity and for the measures of quality for elective 
and non-elective activity, including mental health care delivered in hospitals.
3
  HES comprises almost 
19.1m records for 2012/13, and 19.5m records for 2013/14.  We convert HES records, defined as 
Finished Consultant Episodes (FCEs), into Continuous Inpatient Spells (CIPS), using the official 
algorithm for calculating CIPS published by the Health and Social Care Information Centre.
4
  We then 
count the number of CIPS in each Healthcare Resource Group (HRG), which form the basic means of 
describing different types of hospital output.  
 
The cost of each CIPS is calculated on the basis of the most expensive FCE within the CIPS, with costs 
for each HRG derived from the Reference Cost data.  We then calculate the national average cost per 
CIPS in each HRG.  Reference Cost data are reported according to a classification system in which 
aĐƚŝǀŝƚŝĞƐĂƌĞĚŝǀŝĚĞĚŝŶƚŽ ‘ŵĂƉƉŝŶŐƉŽƚƐ ?ǁŚŝĐŚĐĂƉƚƵƌĞthe method of admission (e.g. 01_EI for 
elective and 02_NEI for non-elective services).  They are then subdivided into department codes (e.g. 
DC for Day case, NEI_L for non-elective long stay and NEI_S for non-elective short stay) which 
capture the Point of Delivery.  Full details are available in the Reference Cost documentation 
(Department of Health, 2012). 
 
For elective activity, the average cost for an HRG is calculated as the activity-weighted average cost 
ŽĨĂůůŽĨƚŚĞ,Z'ĂĐƚŝǀŝƚǇĐŽŶƚĂŝŶĞĚŝŶƚŚĞƌĞĨĞƌĞŶĐĞĐŽƐƚĚĂƚĂŝŶƚŚĞŵĂƉƉŝŶŐƉŽƚ ? ? ?-/ ?ĂŶĚĂ
ĚĞƉĂƌƚŵĞŶƚĐŽĚĞŽĨ ‘/ ? ? This intentionally excludes the use of lower day case costs in the 
calculation of average costs.  For non-elective activity, the average cost is the activity weighted 
ĂǀĞƌĂŐĞƵƐŝŶŐďŽƚŚƚŚĞ ‘E/ ?^ ?ĂŶĚ ‘E/ ?> ?ĚĞƉĂƌƚŵĞŶƚĐŽĚĞƐ ĨƌŽŵƚŚĞ ? ? ? ?E/ ?ƌĞĨĞƌĞŶĐĞĐŽƐƚ
mapping pot. 
 
Frequent changes to the HRG system pose some difficulties in constructing the output index  ?'ƌĂƓŝē
et al., 2015).  In 2012/13, a new version of the patient classification system HRG4+ was introduced, 
replacing the old HRG4 system.  The number of HRGs increased from 1657 to 2100, with only around 
600 overlapping across systems.  In 2013/14 there were further updates to the system; however the 
changes were less dramatic with fewer than 100 HRGs added.  As the changes were not dramatic, 
we were able to use HRG4+ for both years. 
 
 Organisational coverage 3.2.1
The vast majority of activity captured in HES is performed by hospital trusts.  As shown in Table 2, 
97.75% of all FCEs were performed in hospital trusts in 2012/13 and, similarly, 97.54% in 2013/14.  
Activity undertaken by PCTs was still captured in HES in 2012/13 but represented only 0.07% of total 
activity.  With the dissolution of PCTs, their activity has been taken over by trusts, if undertaken at 
all.  The proportion of activity performed by private providers is going up: in 2012/13 they covered 
2.13% of all activity, increasing to 2.41% in 2013/14.   
                                                          
3
 As in previous years, we exclude patients categorised to ,Z'ƐǁŚŝĐŚĂƌĞŶŽƚŝŶĐůƵĚĞĚŝŶƚŚĞƚĂƌŝĨĨ ? “ĞƌŽŽƐƚ,Z'Ɛ ? )
4
 http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=1072 
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Table 2: Organisational coverage of HES activity 
Type of 
organisation 
Year #FCEs Total Cost [in million £] 
Trusts 12/13 18,649,728 16,199 
 13/14 19,061,786 17,517 
PCT 12/13 13,058 1,772 
Private 12/13 406,078 4,313 
 
13/14 470,454 4,394 
Other
5
 12/13 696 223 
 13/14 1,873 301 
 
 Elective, day case and non-elective activity 3.2.2
Elective and day case activity has been increasing over the whole period, while non-elective activity 
shows a more erratic pattern, as can be also observed in Figure 3.  As can be seen from Table 3, the 
number of elective CIPS increased by 311,487 (2.44%) between 2012/13 and 2013/14, while there 
was a decrease in non-elective activity, with 217,283 fewer CIPS  performed in 2013/14 than one 
year earlier.   
 
Table 3: Number of CIPS and average cost for electives and non-electives 
 Elective and day case activity Non-elective activity 
 
# CIPS Average cost # CIPS Average cost 
2004/05 6,433,933 £1,031 6,009,802 £1,210 
2005/06 6,864,612 £1,041 6,291,117 £1,241 
2006/07 7,194,697 £1,036 6,363,388 £1,244 
2007/08 7,598,796 £1,091 6,593,136 £1,237 
2008/09 8,148,229 £1,147 6,826,035 £1,354 
2009/10 8,465,757 £1,227 6,951,379 £1,413 
2010/11 8,755,081 £1,263 7,109,358 £1,460 
2011/12 8,946,909 £1,287 7,049,528 £1,498 
2012/13 9,030,530 £1,341 7,327,228 £1,532 
2013/14 9,342,017 £1,373 7,109,945 £1,543 
 
 
                                                          
5
 Organisations with the org_code starting with 8 
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Figure 3 : Changes in elective and day case and non-elective activity 
 
After cost-weighting this activity, we observe 1.85% growth in activity for electives and negative 
growth of -0.24% for non-elective activity between 2012/13 and 2013/14. Combining both, the 
total cost-weighted activity growth is 0.97%. 
 
 Elective, day case and non-elective activity: quality adjustment 3.2.3
Our measure of hospital output captures growth in both the volume of activity and improvements in 
quality.  The quality of hospital activity is measured by 30-day survival rate and by mean remaining 
life expectancy as well as, in the case of elective and day case activity, by 80
th
 percentile waiting 
times. Information on waiting times is obtained directly from HES; 30-day survival post-discharge is 
calculated from the mortality dataset provided by ONS; mean life expectancy is taken from life 
tables, published by ONS on a yearly basis.
6
  Table 4 and Figure 4 through Figure 6 present average 
values for each of these measures over time. 
 
Table 4: Quality adjustment for elective and day case and for non-elective activity 
 Elective and day case activity Non-elective activity 
 
30-day survival 
rate 
Mean life 
expectancy 
80
th
 percentile 
waiting times 
30-day survival 
rate 
Mean life 
expectancy 
2004/05 99.38% 23.7 104 95.16% 34.1 
2005/06 99.47% 23.7 95 95.49% 34.3 
2006/07 99.51% 23.6 89 95.65% 34.6 
2007/08 99.72% 23.5 74 95.79% 34.7 
2008/09 99.74% 23.2 60 95.85% 34.4 
2009/10 99.76% 23.4 65 96.07% 34.6 
2010/11 99.78% 23.4 76 96.05% 34.8 
2011/12 99.45% 23.19 85 96.62% 34.6 
2012/13 99.50% 23.18 119 96.45% 34.1 
2013/14 99.44% 23.13 94 96.32% 34.1 
                                                          
6
 http://www.ons.gov.uk/ons/rel/lifetables/national-life-tables/index.html 
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Figure 4 : 30-Day survival rate 
 
As can be seen, overall 30-day survival rate decreased slightly in 2013/14.  However, this apparent 
decline in survival rates is mainly due to a trend of increased activity in those HRGs with relatively 
lower survival rates.  In a like-for-like comparison which compares the activity-weighted mean 
difference in survival rates for each HRG that appeared in both years, the mean improvement in 
survival was 0.04% per HRG.  As it is the survival improvement per HRG which enters the quality 
adjustment, there is a positive upward impact of including survival in the quality-adjustment. 
 
There is little variation in mean life expectancy over the entire period, as shown in Figure 5.  A slight 
negative trend can be observed in recent years: this is mostly likely due to an ageing population, 
rather than lower quality of care. 
 
 
Figure 5 : Mean life expectancy 
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Waiting times decreased in 2013/14 compared to 2012/13, as shown in Figure 6.  Despite this 
improvement, waiting times remain much higher than in the 5-year period preceding 2012/13.   
 
 
Figure 6 : 80th percentile waiting times 
 
We calculate quality adjustment based on the performance in a specific HRG, separately for electives 
and non-electives.  The numbers in figures 4 to 7 show overall averages across the relevant sector 
without factoring in any shift of activity towards more complicated cases.  We calculate quality 
adjustments separately for each type of HRG, and separately for electives and non-electives.  When 
we do this, we find that each of our quality adjustors has a positive impact on growth.  Once we take 
quality adjustment into account, the total Laspeyres output growth of HES activity from 2012/13 
to 2013/14 increases from 0.97% to 1.81%.  
 
 Inpatient mental health 3.2.4
tĞŝĚĞŶƚŝĨǇŵĞŶƚĂůŚĞĂůƚŚƉĂƚŝĞŶƚƐĂƐƚŚŽƐĞĨŽƌǁŚŝĐŚƚŚĞ,Z'ĨĂůůƐŝŶƚŽƚŚĞƐƵďĐŚĂƉƚĞƌ “t ?
(Treatment of Mental Health Patients by Non-Mental Health Service Providers).  As seen in Table 5 
and Figure 7, we find some year-on-year fluctuation over the last 10 years in the number of patients 
with mental health problems treated in elective and day case settings, as well as in those receiving 
non-elective treatment.  While the number of non-electives is mostly increasing, the number is 
falling for elective and day case activity.  
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Table 5: CIPS and average cost for inpatient mental health patients 
 Elective and day case activity Non-elective activity 
 
# CIPS Average cost # CIPS Average cost 
2004/05 45,624 £689 123,983 £1,012 
2005/06 41,439 £673 120,203 £1,012 
2006/07 38,408 £656 115,560 £1,012 
2007/08 33,993 £1,141 112,475 £1,364 
2008/09 25,792 £1,133 109,636 £1,319 
2009/10 28,143 £1,195 121,610 £1,365 
2010/11 30,714 £1,297 125,823 £1,445 
2011/12 31,142 £1,318 135,315 £1,318 
2012/13 31,078 £1,358 145,787 £1,358 
2013/14 25,703 £1,368 141,787 £1,385 
 
 
Figure 7 : Number of CIPS for elective, day case and non-elective mental health patients over time 
 
After cost-weighting mental health activity, we observe a decline of -4.95% between the years 
2012/13 and 2013/14.
7
 
 
 Inpatient mental health: quality adjustment 3.2.5
As with other inpatient activity, we also quality-adjust mental health activity. We use the same 
quality adjusters: 30-day survival rates, mean remaining life expectancy and 80
th
 percentile waiting 
times, these measures reported in Table 6.  
  
                                                          
7
 Excluding activity performed at independent treatment centres, quality adjusted output growth equals to 1.44%.  
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Table 6: Quality adjustments for mental health activity 
 Elective and day case activity Non-elective activity 
 
30-day survival 
rate 
Mean life 
expectancy 
80
th
 percentile 
waiting times 
30-day survival 
rate 
Mean life 
expectancy 
2004/05 97.72% 30.1 40 96.96% 28.7 
2005/06 98.01% 30.0 265 97.22% 28.9 
2006/07 98.15% 30.6 257 97.38% 29 
2007/08 98.64% 29.9 28 97.65% 27.7 
2008/09 98.71% 29.0 42 97.56% 27.3 
2009/10 98.61% 29.4 28 97.68% 27.7 
2010/11 98.85% 30.2 37 97.63% 27.8 
2011/12 98.83% 31.1 37 97.78% 27.3 
2012/13 98.41% 29.6 52 97.61% 26.9 
2013/14 98.72% 29.5 56 97.52% 26.9 
 
In the same way as for other HES inpatient activity, we also calculate quality adjustment based on 
the performance in a specific HRG (separated for electives and non-electives).  Once we take quality 
into account, the total Laspeyres output growth of HES activity for mental health patients from 
12/13 to 13/14 decreases further from -4.95% to -5.36%, reflecting recent deteriorations in quality 
for these patients.  
 
 HES outpatient activity 3.2.6
The volume of outpatient activity can be derived from both the HES Outpatient Minimum Dataset 
and RC data, but we always use RC to determine costs.  A like-for-like comparison between the two 
datasets is not wholly possible because the activity data are recorded somewhat differently in each. 
Specifically, this is because it is not possible to classify HES activity into consultant led and non-
consultant led activity which is the common definitional split for non-procedural activity in RC.  For a 
successful match, one would need consultant codes in HES, which are considered sensitive and were 
not available to us.  HES outpatient activity classification is therefore defined as a combination of 
treatment speciality and Secondary Uses Survey (SUS) HRG code.  A further difference between HES- 
and RC-recorded activity is that HES covers activity conducted by organisation types other than 
trusts.  HES contains data on appointments which were attended and those which were not.  For the 
purpose of this analysis we only include attendances which were attended, with these representing 
approximately 80% of recorded data over 2011/12 to 2013/14.  Of non-attended appointments 
there are roughly equal proportions of cancelations by patients, cancelations by providers, and 
patients who failed to attend without prior warning. 
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Table 7 : Organisation and activity coverage over time 
 
2011/12 2012/13 2013/14 
 
Orgs 
Unique 
Activity 
Definitions 
Attended 
Appointments 
[,000s] (% of 
all recorded) 
Orgs 
Unique 
Activity 
Definitions 
Attended 
Appointments 
[,000s] (% of 
all recorded) 
Orgs 
Unique 
Activity 
Definitions 
Attended 
Appointments 
[,000s] (% of 
all recorded) 
Trusts 223 6,800 
69,765   
(79.6%) 
217 7,798 
72,009 
(80.0%) 
219 8,860 
77,559 
(80.2%) 
ISHP 32 619 1,728 (85.3%) 39 774 2,813 (86.9%) 61 957 4,494 (87.4%) 
PCTs 48 551 1,127  (84.3%) 20 307 632 (87.4%) 0 0 0 
CCGs 0 0 - 0 0 0 2 11 1  (77.5%) 
Other 0 0 - 0 0 0 5 28 6  (89.8%) 
 
Table 7 shows the organisational and activity coverage over time.  For trusts, around 220 
organisations have provided data each year, and there has been a steady increase in activity and 
activity definitions over time.  The majority of the activity definition increase appears to be due to an 
increase in procedures that may also be done in hospitals in a day case or elective setting.  For 
example, in 2013/14 there were approximately 9000 different types of activity spread across four 
different types of provider classifications (Hospital Trusts, CCGs, Independent Sector Healthcare 
ƉƌŽǀŝĚĞƌƐĂŶĚ ‘KƚŚĞƌ ?ƉƌŽǀŝĚĞƌƐ ). 
 
There is an increasing number of Independent Sector Health Care Providers (ISHP) providing data for 
an increasing number of categories.  These data are included for completeness, but are excluded 
from our productivity calculations.  These data are excluded as the increase in volume is more likely 
to represent an increase in coverage of an unknown volume of non-NHS activity  W including these 
figures will likely bias the estimates of growth upwards. 
 
PCT activity has, as expected, declined over time and is non-existent in 2013/14.  There is a very 
small amount of CCG outpatient activity from just two CCGs (06H Cambridgeshire & Peterborough 
and 99H Surrey Downs).  There is also a new type of organisational category appearing in 2013/14 
ĐĂůůĞĚ ‘KƚŚĞƌWƌŽǀŝĚĞƌƐ ? ?dŚĞƐĞĨŝǀĞƉƌŽǀŝĚĞƌƐŚĂǀĞĐŽĚĞƐ8F6, 8HP, 8HT, 8J1 and 8J2 and are not 
listed in the HSCIC organisation data service database.  There is, however, only a small amount of 
activity associated with these organisations, and they are excluded from our productivity 
calculations on the same basis as excluding ISHP volume.  The numbers are so small that this 
assumption has no material impact on our measurement. 
 
In order to match consultant-led and non-consultant-led activity definitions from reference costs to 
those in HES, weighted averages were taken to produce averages specific only to currency codes 
(e.g. WF01A) and service codes.  These averages could then be matched to HES activity.  An initial 
round of matching was based on a complete match of reference cost service and currency code 
combination with HES treatment speciality and SUS HRG code.  This led to over 90% of records being 
matched to an associated reference cost.  
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Table 8 : HES outpatient and reference cost matching 
 
11/12 12/13 13/14 
Service & SUS HRG average 85.69% 93.30% 91.61% 
Imputed using HRG average 10.43% 1.72% 0.48% 
Hard-Coded 1.94% 2.34% 2.58% 
Imputed using service average 1.94% 2.65% 5.32% 
Imputed using overall average 0.00% 0.00% 1.00% 
 
For those records with an unattached cost, the HRG average was matched where possible.  In 
2011/12 this led to an additional 10% of records having costs attached, but this figure amounted to 
less than 0.5% in 2013/14.  Inspection of HRGs without any cost data showed a small number of 
HRGs with large volumes, specifically UZ01Z, SC97Z and NZ05C.  UZ01Z and SC97Z HRGs were 
manually assigned zero costs reflecting their zero tariff prices.  NZ05C was assigned a value of £72 
for all years as per the non-mandatory outpatient procedure tariff, as listed in the 2013/14 road test 
tariff spreadsheet.
8
  Remaining activity was either assigned a service-level average or an overall 
reference cost outpatient average. 
 
Table 9 : Volume and average cost over time 
Year 
All providers 
  ?ĞǆĐůƵĚŝŶŐ/^,WĂŶĚ ?other pƌŽǀŝĚĞƌƐ ?) Trusts only 
Volume Average cost Volume Average cost 
2011/12 70,892,793 £113.66 69,765,297 £113.98 
2012/13 72,641,731 £116.39 72,009,479 £116.63 
2013/14 77,560,439 £116.60 77,559,319 £116.60 
 
Table 9 shows the volume of attended activity and average cost of activity for trusts and all providers 
excluding ISHP and other providers (i.e. includes trusts, PCTs and CCGs) over time.  Laspeyres 
growth for all providers was 5.56%, and for trusts only it was 6.26%  
 
 HES Outpatient Activity: quality adjustment 3.2.7
We further quality-adjust outpatient activity to take account of changes in waiting times, as 
summarised in Table 10 and Figure 8.  The average 80
th
 percentile waiting time was 38 days in 
2012/13, rising to 40 days in 2013/14, so accounting for this has only slight impact on the growth 
index which is 5.25% for all providers and 5.55% for trusts only. 
  
                                                          
8
 https://www.gov.uk/government/publications/payment-by-results-pbr-operational-guidance-and-tariffs See 
spreadsheet 07_-_Tariff_information_spreadsheet_2013-14.xls 
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Table 10 Outpatient 80th percentile waiting times 
Waiting time - in days From DH From HES 
2004/05 52 
 
2005/06 46 
 
2006/07 41 
 
2007/08 24 37 
2008/09 22 34 
2009/10 24 36 
2010/11 
 
37 
2011/12 
 
37 
2012/13 
 
38 
2013/14 
 
40 
 
 
 
Figure 8 : Trends in outpatient waiting times 
 
3.3 Reference cost data 
Reference cost returns are used to capture activity performed in most health care settings other 
than hospitals, outpatient departments and primary care.  Since 2012/13 they only cover activity 
undertaken by hospital trusts.  They also provide information on unit costs for these activities (and 
about the costs of activity performed in hospitals and outpatient departments). In particular, RC data 
cover activity conducted in accident and emergency (A&E) departments, mental health and 
community care settings, and diagnostic facilities.  Activities are reported in various ways: 
attendances, bed days, contacts and number of tests. 
 
There are two major issues that need to be considered when using the reference costs data for our 
purposes: 
 
1. The accuracy of the reported data 
2. Their organisational and activity coverage 
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 General RC data validation checks 3.3.1
Recently implemented mandatory and non-mandatory validations of the reference cost data 
returned by NHS Trusts by DH (Department of Health, 2012) have reduced the year-on-year volatility 
in the information contained in the RC returns.  DH checks of the quality of Reference cost returns 
are of the following nature: 
 
x Mandatory validations included checks that all data (both activity and cost) are reported, 
unit costs are reported as positive integers to two decimal places, no fields are missing, etc.  
 
x Non-mandatory validations include checking whether unit costs below £5 or over £50,000 
are accurate and whether single professional outpatient attendance unit costs were less 
than multi-professional unit costs.  
 
x &ŝŶĂůůǇ ?ĐŚĞĐŬƐŽŶ ‘year-on-year ĐŚĂŶŐĞƐ ?ĂƌĞĐĂƌƌŝĞĚŽƵƚ ?/ŶƉĂƌƚŝĐƵůĂƌ ?ĂŶǇĐŚĂŶŐĞŝŶƚŽƚĂů
cost or activity greater than 25% is flagged and followed up. The check is carried out by 
department code and HRG sub-chapter for acute services, or service code for non-acute 
services (only for outpatient attendances, outpatient procedures and emergency medicine). 
 
Over and above these checks, we have implemented our own validation process (Bojke et al., 2014). 
These focus on identifying large increases/decreases in either volume or unit costs of activity for all 
non-acute services.  In particular, we check 1) whether volumes of activity have registered either an 
increase or decrease of more than 500,000 units or 2) whether the value of activity has registered an 
increase or decrease of more than £25 million.  
 
For 2013/14, a further check has been implemented which looks at the impact of valuing current 
ƵŶŝƚƐŽĨŽƵƚƉƵƚĂƚůĂƐƚǇĞĂƌ ?ƐƉƌŝĐĞƐ ?ĂŶĞĐĞƐƐĂƌǇƐtep in the construction of the Laspeyres index).   
 
In the event that large scale changes are detected, we look at each activity in isolation to determine 
the most appropriate solution.  These may be: to leave as is, replace an unexpected high cost value 
with the minimum cost across the two years, or omit the category from the output index.  Our 
validation checks performed with the RC 2013/14 data do not show any implausibly large changes.  
 
 Organisational and activity coverage 3.3.2
RC data are always subject to some degree of change over time both in terms of organisational 
coverage, and of coverage and definition of activities: PCT data were, for example, not collected in 
2012/13 despite some PCTs still being active to some degree.  Although CCGs and CSUs have 
replaced the commissioning role that PCTs used to have, they are not thought to directly produce 
any healthcare outputs.  As such, we anticipate that there is little or no CCG or CSU activity that 
could potentially be collected in RCs.  As such, organisational coverage between 2012/13 and 
2013/14 has been stable.   
 
In contrast, the number and definitions of individual categories has changed considerably over time, 
as observed in Table 11.  This shows that the major change was between 2011/12 and 2012/13, with 
a substantial increase in the number of distinct categories from 3,586 to 16,106, although this 
number reduced to 10,209 in 2013/14.  Between 2011/12 and 2012/13 there were major changes in 
the definition of measurement of mental health, community care and accident and emergency, as 
described in our previous report (Bojke et al., 2015).   
 
Although there has been no major restructuring between 2012/13 and 2013/14, a large number of 
category definitions have changed.  Figure 9 shows a Venn diagram with each set representing 
category definitions within a financial year, and the overlap in definitions over time.  For example 
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there are 1,633 categories which appear in all 3 years.  Of note are the 5,257 (293 + 4,964) 
categories in 2013/14 that were not present in 2012/13, although 293 of these categories appeared 
ŝŶ ? ? ? ? ? ? ? ?dŚĞƐĞ ‘ŶĞǁ ?ĐĂƚĞŐŽƌŝĞƐƌĞƉƌĞƐĞŶƚ ? ?ŵƵŶŝƚƐŽĨĂĐƚŝǀŝƚǇǁŝƚŚĂƚŽƚĂůĐŽƐƚŽĨĂƉƉƌŽǆŝŵĂƚĞůǇ
£5.5bn (approx. 16% of all cost-weighted activity in 2013/14).  Conversely there are 11,154 (97 + 
11,057) categories which appeared in 2012/13 but which no longer appear in 2013/14.  These 
categories had 39.5m units of activity with a total cost of approximately £4.5bn (14%).  These 
substantial year-on-year categorisation changes make it challenging to measure output growth over 
time. 
 
Table 11: Categorisation over time in reference costs 
 
2011/12 2012/13 2013/14 
Distinct Categories 3,586 16,106 10,209 
Units of Activity 780,901,098 826,542,379 863,298,804 
Unadjusted Cost £        30,680,190,774 £        31,770,599,163 £        34,025,100,192 
Table excludes hospital based activity covered by HES e.g. elective, non-elective and certain mental health activities (but 
includes outpatient activity) 
 
 
 
Figure 9 :  Venn diagram of reference cost activity definitions 11/12 to 13/14 
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Table 12: Reference cost settings 
Setting 
2012/13 2013/14 
Categories Activity Cost Categories Activity Cost 
A&E and Ambulance Services 89 34,952,786 £3,692,014,018 90 35,051,392 £3,923,106,579 
Chemo/Radiotherapy & High Cost Drugs 317 6,754,603 £2,652,051,626 323 6,988,301 £2,915,174,231 
Community Care 149 79,709,044 £4,139,765,181 174 85,975,592 £4,864,684,367 
Diagnostic Tests 64 342,280,609 £941,490,357 72 368,505,992 £964,981,062 
Community Mental Health 117 260,266,214 £6,311,927,307 124 259,659,214 £6,410,525,825 
Outpatient 6,979 77,222,725 £8,546,218,360 8,055 81,699,802 £9,275,173,143 
Radiology 5,047 9,381,616 £859,058,674 136 9,709,456 £904,796,391 
Rehabilitation 119 2,715,650 £817,792,033 113 3,002,512 £893,588,640 
Renal Dialysis 40 4,135,914 £528,076,698 40 4,079,238 £533,459,915 
Specialist Services 86 4,359,263 £2,927,444,066 145 4,699,893 £3,030,502,560 
Other 3,099 4,763,955 £354,760,843 937 3,927,412 £309,107,379 
 
Table 12 summarises the RC data according to broad service settings.  This shows that nearly half the 
dropped categories appeared in radiology (down from 5,047 categories to just 136).  However, the 
total activity within the radiology setting increased from 9.3m to 9.7m and the total cost from 
£860m to £905m.  This is indicative of a change in activity definition with a move to broader and less 
granular definitions.  A similar situatiŽŶŽĐĐƵƌƐŝŶƚŚĞ ‘KƚŚĞƌ ?ƐĞƚƚŝŶŐ ?ǁŚĞƌĞƚŚĞůĂƌŐĞƐƚĐŽŵƉŽŶĞŶƚ
of Regular Day and Night Attendances (RDNA) activity drops from 3,084 different definitions to just 
919 types. 
 
We deal with each of these changes in more detail in their relevant sections, but the main 
conclusion is that there are no substantial consequences for RC growth measurement.  This is 
because, although category descriptions differ, the old and new categories are capturing the same 
types of activity. 
 
 RC outpatient activity 3.3.3
Outpatient activity as measured in the RC database has tended to be classified into three major 
groups: consultant led activity; non-consultant led activity; and procedures.  Consultant and non-
consultant led activity represent broadly the same set of outpatient specific HRG-style codes 
(currency codes beginning with WF) and outpatient procedure codes represent procedure related 
HRGs which may appear in other hospital settings (for example in 2013/14 reference costs, HRG 
AA21G [minor intracranial procedures] occurred 1,648 times as a hospital day case and 3,662 times 
as an outpatient procedure).  On average, consultant led activity for trusts represents over 71% of 
overall outpatient cost-weighted activity. Outpatient procedures have increased considerably in 
volume: representing just 3% of overall outpatient activity in 2007/08 and nearly 12% in 2013/14. 
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Table 13: Outpatient activity and cost 
Year 
All providers Trusts only 
Volume 
Average 
cost 
Volume 
Average 
cost 
2007/8 69,679,600 £94.04 61,508,362 £98.40 
2008/9 74,421,017 £98.36 65,804,814 £102.79 
2009/10 80,093,906 £101.47 71,115,142 £105.30 
2010/11 81,301,615 £105.37 73,621,984 £107.11 
2011/12 
  
75,826,947 £108.23 
2012/13 
  
77,222,725 £110.67 
2013/14 
  
81,699,802 £113.53 
 
The Laspeyres index of growth for outpatient activity was 7.79% from 2012/13 to 2013/14 and 
7.78% after adjusting for quality.  
 
The difference between HES and RC measures of growth is fairly substantial and amounts to 2.23% 
difference with HES quality-adjusted growth measured at 5.55%.  Although both datasets have some 
quality issues, our preferred method is using HES, as it is a patient level dataset as opposed to the 
more aggregated RC. This allows us to perform more thorough quality checks and better assure a 
like-for-like comparison.  
 
 A&E and ambulance services 3.3.4
Table 14 reports summary statistics for A&E services provided in Emergency Departments and Other 
A&E services according to whether patients were subsequently admitted to hospital (AD) or not 
admitted (NAD).  
 
Emergency departments offer a consultant-led 24 hour service with full resuscitation facilities and 
designated accommodation for the reception of A&E patients.
9
  Between 2012/13 and 2013/14 
there was a slight decrease (of 1.6%) in the total number of emergency department attendances, 
with the greatest drop occurring in the A&E attendances leading to people being admitted to 
hospital. 
 
dŚĞĐĂƚĞŐŽƌǇ ‘KƚŚĞƌA&E services ? captures activities carried out in any of the following 
ĚĞƉĂƌƚŵĞŶƚƐ P ‘ŽŶƐƵůƚĂŶƚůĞĚŵŽŶŽƐƉĞĐŝĂůƚǇĂĐĐŝĚĞŶƚĂŶĚĞŵĞƌŐĞŶĐǇƐĞƌǀŝĐĞƐ ?Ğ ?Ő ?ŽƉŚƚŚĂůŵŽůŽŐǇ ?
ĚĞŶƚĂů )ǁŝƚŚĚĞƐŝŐŶĂƚĞĚĂĐĐŽŵŵŽĚĂƚŝŽŶĨŽƌƚŚĞƌĞĐĞƉƚŝŽŶŽĨƉĂƚŝĞŶƚƐ ? ? ‘KƚŚĞƌƚǇƉĞŽĨ ? ?ŵŝŶŽƌ
injury activity with designated accommodation for the reception of accident and emergency 
ƉĂƚŝĞŶƚƐ ?ĂŶĚ ‘E,^tĂůŬ-in-ĞŶƚƌĞƐ ? ? Overall, the total volume of A&E activity increased by 0.62% 
between 2012/13 and 2013/14. 
  
                                                          
9
 http://www.hscic.gov.uk/article/3966/HES-AE-Data-Dictionary 
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Table 14: A&E activity and average cost 
Year 
Emergency Departments Other A&E services 
AD NAD AD NAD 
Volume of 
activity 
Average 
cost 
Volume of 
activity 
Average 
cost 
Volume of 
activity 
Average 
cost 
Volume of 
activity 
Average 
cost 
2006/7 3,464,869 107 10,327,147 83 281,135 50 3,900,718 36 
2007/8 3,326,719 121 9,058,765 89 531,498 70 3,769,765 43 
2008/9 3,566,642 118 9,708,958 99 1,000,986 49 4,184,796 49 
2009/10 4,047,176 134 10,075,701 103 1,090,650 49 3,628,469 50 
2010/11 4,004,868 141 9,881,747 108 1,145,125 62 3,800,261 55 
2011/12 4,040,760 157 10,405,762 108 616,812 83 3,253,452 52 
2012/13 4,345,100 160 10,292,933 115 362,656 90 3,426,231 59 
2013/14 4,218,480 177 10,189,225 127 494,549 80 3,639,355 59 
Legend: AD  W leading to admitted patient care; NAD  W Not leading to admitted patient care 
 
 
 
Figure 10: trend of A&E activity across settings 
 
Ambulance services are reported in Table 15 for the three years since their introduction in the 
Reference cost database.  Activity is measured in terms of calls ƌĞĐĞŝǀĞĚĨŽƌƚŚĞĐĂƚĞŐŽƌǇ ‘ĂůůƐ ? ?
patients ĨŽƌƚŚĞĐĂƚĞŐŽƌǇ ‘,ĞĂƌ ?ĂŶĚincidents ĨŽƌƚŚĞĐĂƚĞŐŽƌǇ ‘^ĞĞ ? ? Both the number of calls and 
ƚŚĞƚŽƚĂůŶƵŵďĞƌŽĨƉĂƚŝĞŶƚƐĨŽƌƚŚĞĐĂƚĞŐŽƌǇ ‘,ĞĂƌ ?ĚĞĐƌĞĂƐĞĚŝŶ ? ? ? ? ? ? ? ?ǁŚŝůƐƚƚŚĞƚŽƚĂůŶƵŵďĞƌ
of incidents ĨŽƌƚŚĞĐĂƚĞŐŽƌǇ ‘^ĞĞ ?have increased year-on-year since 2011/12. 
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Table 15 Ambulance services 
 
2011/12 2012/13 2013/14 
Ambulance Services 
   
    
Calls 
   
Volume of activity 8,530,563 9,120,422 8,926,215 
Average cost (£) 8 7 7 
    Hear and treat or refer 
   
Volume of activity 338,022 423,821 400,005 
Average cost (£) 44 47 44 
    See and treat or refer 
   
Volume of activity 1,862,892 1,997,327 2,113,757 
Average cost (£) 173 174 180 
    See and treat and convey 
   
Volume of activity 4,895,376 4,984,296 5,069,806 
Average cost (£) 230 230 231 
     
The Laspeyres ŽƵƚƉƵƚŐƌŽǁƚŚŵĞĂƐƵƌĞĨŽƌƚŚĞƐĞƚƚŝŶŐ ? ?ƐĞƌǀŝĐĞƐ ? ?ǁŚŝĐŚŝŶĐůƵĚĞƐĂŵďƵůĂŶĐĞ
services, increased by 3.04% between 2012/13 and 2013/14. 
 
 Chemotherapy, radiotherapy and high cost drugs 3.3.5
The categories used to describe chemotherapy, radiotherapy, and high cost drugs have been subject 
to substantial revision over time, making it difficult to infer much from the simple counts of activity 
reported in Table 16.  Between 2012/13 and 2013/14, however, categorisation has been stable, with 
the total volume of Chemotherapy activity increasing by 0.6%, that of Radiotherapy by 1.6% and that 
of High Cost Drugs by 11.6%.  
 
The Laspeyres output growth measure for Chemotherapy, Radiotherapy & High Cost Drugs was 
9.3% between 2012/13 and 2013/14.  Although this rate is high, it is smaller than in previous years, 
as can be seen in Figure 11.  
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Table 16 Chemotherapy, radiotherapy, high cost drugs 
Year 
Chemotherapy Radiotherapy High cost drugs 
Volume of 
activity 
Average 
cost 
Volume of 
activity 
Average 
cost 
Volume of 
activity 
Average 
cost 
2004/5 777,312 363 1,622,278 113 - - 
2005/6 763,806 432 1,634,156 126 - - 
2006/7 1,642,444 280 1,743,490 123 26,277,491 17 
2007/8 846,425 406 1,613,135 559 1,332,996 305 
2008/9 1,428,561 448 1,710,525 157 1,322,354 473 
2009/10 1,414,872 505 1,835,695 163 2,412,988 384 
2010/11 1,515,845 515 2,001,798 161 1,288,460 818 
2011/12 1,769,727 505 2,492,431 137 1,372,131 902 
2012/13 2,525,935 387 2,717,024 127 1,511,644 878 
2013/14 2,540,353 431 2,760,237 134 1,687,711 859 
Note: In 2006/7, high cost drugs were recorded as number of procurements, after which recording was by number of 
patients 
 
 
Figure 11: Laspeyres output growth for chemotherapy, radiotherapy and high cost drugs over time 
 
 Community care 3.3.6
Table 17 reports total volumes of community care activity from 2004/05 to 2013/14.  While the 
provision of community care has decreased since 2009/10, this is primarily due to PCTs (and 
Personal Medical Services pilots) no longer reporting this activity after 2010/11.  Community care 
activity increased by 6 million units of activity (7.9%) between 2012/13 and 2013/14. 
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Table 17 Community care activity 
Year 
Community care 
Volume of activity (a) Average cost (£) 
2004/5 75,673,792 39 
2005/6 85,092,838 38 
2006/7 83,895,139 40 
2007/8 85,470,688 42 
2008/9 88,513,663 45 
2009/10 92,412,727 46 
2010/11 90,724,524 47 
2011/12 78,315,576 50 
2012/13 79,709,044 52 
2013/14 85,975,592 57 
Notes: (a) In 2011/12, PCTs and PMS ceased to report activity about community care. Total volume of activity from 
2011/12 is, therefore, not comparable with previous years. 
 
Table 18: Trends in community care activity 
 
 
The RC data and documentation (Department of Health, 2014) reveal three types of activities newly 
introduced in 2013/14: Community Intermediate care activity, Wheelchair services and Other 
Therapists. 
 
1. Community Intermediate care activity: Three new categories of intermediate care services 
have been created to align three existing classes of categories: admission avoidance 
schemes; community rehabilitation teams; and hospital at home and early discharge 
schemes.  Whilst the realignment of existing services may create a small issue of assigning 
the correct lagged cost, there is an additional problem in that not all the covered services 
appear to have been collected in previously  W there are no obvious past RC categories that 
cover admission avoidance schemes.  In addition, there appears to be no smooth mapping of 
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the two pre-existing categories (community rehabilitation teams and hospital at home and 
early discharge schemes).  For example, the three new categories cover 5.7m units of activity 
and have a cost-weighted value of £650m with only one category having (just) fewer than 
1m units of activity.  Hospital at Home and Early Discharge Scheme categories accounted for 
286k units of activity in 2012/13, with a cost-weighted value of £31m, and community 
rehabilitation teams also covered approximately 285k units of activity, with a cost-weighted 
value of £197m.  As the new and old categories do not appear to align at all, for the base 
case calculation of output growth we have opted to drop the lagged-cost weighted value of 
the new intermediate care services from the numerator of the Laspeyres volume index.  In 
order to compare like with like, we also drop community rehabilitation teams and hospital at 
home and early discharge schemes from in 12/13.  
 
2. Wheelchair services: 2013/14 also saw the introduction of 26 new wheelchair categories 
with nearly 650k units of activity and a cost-weighted value of £137m.  Our understanding is 
that this is new recording of an existing activity which was previously unrecorded. Therefore 
inclusion of this data would falsely over-estimate growth because the activity was previously 
uncounted.  Our solution is to omit this category from the growth calculation until data are 
available for at least two years.   
 
3. Other Therapists:  ? ? ? ? ? ? ?ĂůƐŽƐĂǁƚŚĞŝŶƚƌŽĚƵĐƚŝŽŶŽĨ ‘KƚŚĞƌdŚĞƌĂƉŝƐƚƐ ?categories to 
cover art, drama and music therapists and complementary or alternative medicine 
therapists.  There are 4 new categories with nearly 250k units of activity and a cost-weighted 
value of £19m.  As with wheelchair services, we believe that these categories represent new 
recording of an existing service and so we omit them from the current calculation. 
 
The total volume of the new three new types of activities introduced in 2013/14 is equal to over 6.5 
million units of activity. This explains much of the recorded increase in Community Care activity 
between 2012/13 and 2013/14.  If including these three newly introduced activities, output growth 
for the Community Care setting is 17.4%.  Dropping the new activity (and partly displaced old 
activity) from the calculation gives a Laspeyres growth of 3.2%
10
. 
  
                                                          
10
 As part of the unmapped and non-comprehensive previous activity now included in intermediate care both lagged 
Hospital at Home (285,754 units) and lagged community rehabilitation team activity (2,851,158 units) were also dropped 
from the calculation. EŽƚĞ ƚŚĂƚ ƚŚĞ,ŽƐƉŝƚĂůĂƚ,ŽŵĞĂĐƚŝǀŝƚǇŚĂĚƉƌĞǀŝŽƵƐůǇ ďĞĞŶ ŝŶĐůƵĚĞĚ ŝŶ ƚŚĞ  ‘KƚŚĞƌ ?ƐĞƚƚŝŶŐ ƌĂƚŚĞƌ
than community care. 
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 Diagnostic tests, pathology and radiology 3.3.7
Table 19: Directly accessed diagnostic and pathology services and radiology 
Year 
Directly accessed 
diagnostic services 
Directly accessed 
pathology services 
Radiology 
Volume of 
activity 
Average 
cost 
Volume of 
activity 
Average 
cost 
Volume of 
activity 
Average 
cost 
2004/5 369,988 44 180,676,234 3 5,152,720 31 
2005/6 465,622 44 221,966,384 2 5,784,605 33 
2006/7 735,569 137 236,269,050 2 23,918,500 59 
2007/8 776,368 41 257,249,379 2 7,614,437 103 
2008/9 804,607 46 278,917,852 2 7,852,498 102 
2009/10 1,063,744 43 300,010,031 2 8,347,404 104 
2010/11 1,458,025 39 320,418,662 2 8,491,834 97 
2011/12 5,640,762 34 333,108,317 2 8,758,136 93 
2012/13 6,339,016 30 335,941,593 2 9,381,616 92 
2013/14 6,553,727 31 361,952,265 2 9,709,456 93 
Note: In 2004/05 and 2005/06, radiology was recorded as number of tests; in 2006/7 it comprised number of tests and 
interventions; from 2007/08 it was number of patients. 
 
The number of distinct categories in Radiology fell from 5,047 categories to just 136.  Further 
inspection revealed this to be a result of a decrease in the granulation of measurement.  For 
example, whilst the currency code RA01A (MRI Scan, one area, no contrast, age 19 years or over) 
appeared in 176 distinct categories in 2012/13 due to service description (Direct Access, Outpatient 
and Other) and  “further service information ? (general surgery to chemical pathology and global trust 
codes), it only appears in three distinct codes in 2013/14, sub-divided by service description (Direct 
Access, Outpatient and Other).  /ƚĂƉƉĞĂƌƐƚŚĂƚƚŚĞ “further service information ? is no longer 
recorded.  The definitions of RA01A in 2013/14 have reverted to what they were in 2011/12.   
 
This creates a minor issue with constructing the Laspeyres index, as we are required to weight 
ĐƵƌƌĞŶƚĂĐƚŝǀŝƚǇďǇůĂƐƚǇĞĂƌ ?ƐĐŽƐƚƐ ?/ŶƚŚĞĐĂƐĞŽĨƚŚĞthree 2013/14 RA01A types of activity we do 
ŶŽƚĂƵƚŽŵĂƚŝĐĂůůǇŚĂǀĞƚŚĞĞƋƵŝǀĂůĞŶƚŽĨůĂƐƚǇĞĂƌ ?ƐĐŽƐƚƐ ?KƵƌŐĞŶĞƌĂůĂƉƉƌŽĂĐŚƚŽƐƵĐŚŝƐƐƵĞƐŚĂƐ
been to impute lagged costs from the nearest available observed cost or, in cases where we have 
observations either side of a missing cost, the geometric mean.  As the 2013/14 definitions match 
the 2011/12 definitions, the imputed cost is the average of the observed costs at 2013/14 and 
2011/12.  For example in the case of Outpatient RA01A the observed cost in 2013/14 was £144.60 
and the equivalent cost in 2011/12 was £144.51.  The imputed lagged cost for 2013/14 is therefore 
£144.56.  An alternative approach would be to consolidate the more granular 2012/13 definitions 
into definitions that match 2013/14.  In this case the consolidated average cost for Outpatient 
RA01A would be £148.18.  Given the minimal differences between the approaches we have applied 
the imputation approach rather than adopting a piece-meal matching process. 
 
The total volume of Directly Accessed Diagnostics services, Directly Accessed Pathology services and 
Radiology increased by 3.39%, 7.74% and 3.35% respectively.  The Laspeyres output growth for 
each category was 2.27%, 18.9% and 7.45% respectively, leading to an overall growth for these 
combined activities of 11.70%.  Although this represents a large growth it is not out of line with 
historical growth in these areas, and represents a small component (1.34%) of output overall. 
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 Community mental health 3.3.8
Table 20 summarises overall counts of community mental health activity since 2004/5.  Activity in 
this setting underwent a major revision in 2011/12 with the creation of mental health clusters but 
has since appeared to settle into a consistent measurement scheme.  Table 21 provides a more 
detailed breakdown of community mental health activity since the clusters were first employed. 
 
Table 20 Community mental health 
Year 
Community mental health 
 
Volume of activity Volume of activity (a) Average cost (£) 
2004/5 16,389,891 
 
164 
2005/6 17,738,894 
 
170 
2006/7 19,259,205 
 
167 
2007/8 21,751,043 
 
153 
2008/9 22,674,811 
 
157 
2009/10 23,440,616 
 
161 
2010/11 24,341,950 
 
159 
2011/12 
 
224,329,080 28 
2012/13 
 
260,266,214 24 
2013/14 
 
259,659,214 25 
Notes: (a) Due to reclassification of activity in community mental health, data is not directly comparable with data reported 
in previous years. 
 
Table 21: Care clusters and other mental health activity 
Community mental health 
2011/12 2012/13 2013/14 
Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Volume of 
activity 
Average 
cost (£) 
Care Clusters 
      
Mental Health  W Care Clusters  W 
Admitted Patient Care 
5,900,173 334 5,548,751 348 8,822,616 222 
Mental Health - Care Clusters - 
Non-Admitted Patient Care 
208,657,970 11 244,072,900 9 239,045,781 9 
Mental Health  W Care Clusters  W 
Initial Assessment 
418,356 251 816,112 264 746,982 281 
      dŽƚĂůǀŽůƵŵĞ ?DĞŶƚĂů,ĞĂůƚŚĂƌĞ
ůƵƐƚĞƌƐ ? 214,976,499 20 250,437,763 17 248,615,379 17 
      Other Mental Health 
     
Secure Units 1,537,140 523 1,526,840 532 1,543,448 516 
Day Care Facilities: Regular 
Attendances 
28,782 294 34,969 294 41,555 305 
Outpatient Attendances
*
 1,343,458 156 615,632 217 721,849 182 
Community Contacts 3,309,410 135 2,970,529 161 2,642,912 188 
Specialist Teams 3,133,791 140 4,680,481 120 6,094,071 117 
      Total volume Other Mental Health 9,352,581 204 9,828,451 203 11,043,835 195 
      Total volume of Community MH 
activity 
224,329,080 28 260,266,214 24 259,659,214 25 
In terms of raw activity, community mental health increased by 2.9% from 2012/13 to 2013/14.  The 
initial Reference cost data published on the website suggest an increase of 18.7% between 2012/13 
Poductivity of the English NHS: 2013/14 update   27 
and 2013/14 but this was an artefact created by incorrect by one trust (Sussex Partnership NHS 
Foundation Trust). The figures on the website were subsequently corrected.  
 
Once the data from this Trust are omitted, we observe a slight decrease in cost weighted activity 
between years 2012/13 and 2013/14.  Laspeyres output growth for community mental health 
equals to -0.45%. 
 
 Rehabilitation and renal dialysis 3.3.9
Table 22 Rehabilitation and renal dialysis 
Year Rehabilitation Renal dialysis 
Volume of activity Average cost Volume of activity Average cost 
2004/5 4,095,087 178 8,232,432 52 
2005/6 4,509,489 185 6,819,136 64 
2006/7 3,028,598 241 4,200,298 104 
2007/8 2,732,048 259 3,980,793 114 
2008/9 3,277,757 265 4,091,245 120 
2009/10 3,277,430 279 4,050,658 129 
2010/11 3,314,085 285 4,088,817 129 
2011/12 2,897,721 278 4,166,150 129 
2012/13 2,715,650 301 4,135,914 128 
2013/14 3,002,512 298 4,069,460 131 
 
The total volume of Rehabilitation services increased by 10.6% between 2012/13 and 2013/14, 
whilst the total volume of Renal Dialysis decreased by 1.6% over the same time period.  The 
Laspeyres output growth for Rehabilitation and Renal Dialysis services were, respectively, 12.1% 
and 0.3% between 2012/13 and 2013/14.  
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 Specialist services 3.3.10
The volume and cost of various types of specialist services are reported in Table 23. 
 
Table 23: Specialist services  
Year 
Adult Critical Care 
Specialist Palliative 
Care 
Cystic Fibrosis 
Cancer Multi-
Disciplinary Team 
Meetings 
Volume 
of activity 
Average 
cost 
Volume 
of activity 
Average 
cost 
Volume 
of activity 
Average 
cost 
Volume 
of activity 
Average 
cost 
2004/5 2,184,333 828 - - 16,317 1,919 - - 
2005/6 2,197,135 895 - - 13,704 2,316 - - 
2006/7 2,468,777 840 93,880 269 13,944 2,290 - - 
2007/8 2,165,060 931 208,410 219 15,383 2,349 - - 
2008/9 2,354,447 967 262,305 216 20,756 2,116 - - 
2009/10 2,439,661 1,003 359,121 192 20,323 2,468 - - 
2010/11 2,470,065 1,011 512,972 162 19,942 2,631 - - 
2011/12 2,570,571 998 550,417 166 9,852 8,476 837,418 114 
2012/13 2,669,343 984 600,848 169 9,735 8,709 1,079,297 106 
2013/14 2,708,897 992 701,439 158 9,990 10,213 1,279,567 101 
 
Adult critical care services have become more granular in 2013/14 compared to 2012/13, expanding 
from 20 to 81 different types of services.  No mapping between the new categories and the old ones 
was possible. 
 
The total volume of Critical Care services increased by 1.5%, that of Specialist Palliative care by 
16.7%, that of Cystic Fibrosis by 2.6% and that of Cancer Multi-Disciplinary Team Meetings activity 
by 18.6% between 2012/13 and 2013/14. 
 
Taken together, Laspeyres output for these specialist services grew by 3.5% between 2012/13 and 
2013/14. 
 
 Other reference cost activities 3.3.11
Other types of activity reported in the reference costs are summarised in the following tables.  The 
way of classifying these activities has changed somewhat over time, so rarely are the series recorded 
in a consistent fashion across all years.  Some recording of some types of activity are occasionally 
discontinued, or subsumed under other broad categories.  
  
Poductivity of the English NHS: 2013/14 update   29 
Table 24 Regular admissions, ward attenders and day care 
Year Regular day and night 
admissions 
Audiological 
services 
Day care facilities Hospital at home 
Volume of 
activity 
Average 
cost 
Volume 
of activity 
Average 
cost 
Volume 
of 
activity 
Average 
cost 
Volume of activity Average 
cost 
2004/5 122,447 248 1,902,390 41 735,070 124 434,698 73 
2005/6 177,131 245 1,692,721 40 649,963 131 593,586 60 
2006/7 179,927 271 2,905,175 50 439,932 135 470,737 74 
2007/8 164,651 324 3,447,049 51 384,048 137 405,271 73 
2008/9 198,573 341 3,716,333 51 345,371 159 522,047 68 
2009/10 152,079 393 3,807,539 52 319,706 156 495,961 81 
2010/11 176,169 431 3,927,780 51 321,386 148 364,352 91 
2011/12 176,877 428 4,033,290 50 275,819 140 323,213 113 
2012/13 210,984 371 4,030,693 52 237,040 157 285,754 108 
2013/14 204,831 400 3,483,549 55 239,032 146 0 - 
 
The total volume of Regular Day and Night Admissions (RDNA) activity decreased by 2.9%, whilst 
that of patients treated in Day Care Facilities increased by 0.8% between 2012/13 and 2013/14. The 
total volume of audiological services decreased by 13.6% between 2012/13 and 2013/147.  Hospital 
at Home services are now covered under Community Intermediate Care activities in the community 
care setting. 
 
The cost-ǁĞŝŐŚƚĞĚŽƵƚƉƵƚŐƌŽǁƚŚŵĞĂƐƵƌĞĨŽƌ ?KƚŚĞƌE,^ĂĐƚŝǀŝƚǇ ? is negative, at -5.5%, between 
2012/13 and 2013/14. 
 
 Total reference cost growth 3.3.12
 
Including outpatient data, the activities recorded in the reference cost returns grew by 4.81% from 
2012/13 to 2013/14.  The growth was mainly a result of the larger categories (A&E, Community 
Care, Mental Health and Specialist services) growing at around 3%, with a number of the smaller 
categories (Chemo/Radiology and High Cost Drugs ; Diagnostic Tests, Radiology ; and Rehabilitation) 
all showing growth above 7.5%. Excluding Outpatient activity, the data contained in Reference cost 
returns suggest that output grew by 3.70% from 2012/13 and 2013/14.  
 
3.4 Dentistry and ophthalmology 
Information about dentistry is derived from the HSCIC website
11
 with dental activity differentiated 
into dental bands, as shown in Table 25.  The HSCIC publication on NHS Dental Statistics also reports 
a weighted measure of courses of treatments, Units of Dental Activity (UDA), which reflect the 
relative costs of different courses of treatments.  We use UDA measures to construct the Laspeyres 
growth measure for dentistry.
12
  
  
                                                          
11
 http://www.hscic.gov.uk/catalogue/PUB11625 
12
 Prior to 2011/12 we used unit costs of dental treatment as weights, but these proved equivalent to the underlying 
weights used to construct UDAs. 
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Table 25: Dental services 
Year  Dentistry  
Band 1 Band 2 Band 3 Urgent Other   Total 
 (UDA)     
2004/5
*
 - - - - -   68,983,268 
2005/6
*
 - - - - -   69,863,311 
                
2006/7 19,012,890 32,063,007 18,349,548 3,457,446 767,309  73,650,200 
2007/8 19,275,334 32,975,610 20,214,444 3,759,851 735,804   76,961,043 
2008/9 19,803,371 34,468,755 22,314,288 4,012,151 755,832   81,354,397 
2009/10 20,346,012 35,098,905 25,034,148 4,210,866 767,980   85,457,911 
2010/11 20,718,874 35,414,322 26,249,796 4,338,032 743,265   87,464,289 
2011/12 20,886,648 35,586,987 26,604,720 4,422,493 742,657   88,243,506 
2012/13 21,016,444 35,252,547 26,871,444 4,454,437 502,932   88,097,804 
2013/14 21,685,314  35,404,479  26,786,916  4,622,964  191,761    88,691,434  
 
As shown in Figure 12, dental output went up in all bands over time, with a slight increase 
between years 2012/13 and 2013/14.  The Laspeyres growth rate is 0.54% for this period. 
 
 
Figure 12: Number of dentistry consultations over time 
 
Data about the volume of activity for community ophthalmology is published by HSCIC on a yearly 
basis
13
. Table 26 presents the volume of activity and cost for ophthalmic services over time.   
  
                                                          
13
 http://www.hscic.gov.uk/catalogue/PUB11233 
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Table 26: Volume and average cost in community ophthalmology 
Year Ophthalmology 
Volume of 
activity 
Average 
cost 
2004/5 10,148,978 33 
2005/6 10,354,682 35 
2006/7 10,484,922 36 
2007/8 11,047,890 28 
2008/9 11,278,474 28 
2009/10 11,811,651 28 
2010/11 11,938,529 28 
2011/12 12,305,727 28 
2012/13 12,339,253 28 
2013/14 12,787,430 28 
 
There was an increase in ophthalmic activity between the years 2012/13 and 2013/14, leading to 
cost-weighted output growth of 3.63%. 
 
3.5 Primary care activity 
As in previous years, comprehensive data covering primary care activity remains unavailable.  For 
the period 2004/05 to 2008/09 the volume of GP consultations was obtained from QResearch (Fenty 
et al., 2006, QResearch, 2009).  When this survey was discontinued, we initially instead used the 
General Lifestyle Survey from 2009/10 to 2010/11 (Bojke et al., 2012) and, since 2010/11, we have 
used data from the GP Patient Survey.
14
  The survey has been running since 2007 in different time 
intervals; since 2011 it has been conducted every six months.  In the last round, some 1.32m 
patients were sent a questionnaire between July and September 2014.  The current response rate is 
around 34%.
15
  To assess how much activity is undertaken in primary care, we look at the percentage 
of participants who answered that they had seen or spoken to their GP in the last 3 months.  The 
responses are weighted to ensure they are representative of the general population. 
 
In the absence of recent information, we assume that the proportion of each consultation type has 
remained unchanged since 2008/09.  The cost of primary care activity comes from an annual 
calculation published by Personal Social Services Research Unit (PSSRU) and available online.
16
  For 
2013/14 the cost of GP home visits is not available; therefore, we use the same cost as last year, 
inflated by the general increase in total GP cost.  
 
In 2013/14 the percentage of people who saw or spoke to GP in the last 3 months declined from 
54.83% in 2012/13 to 54.28% in 2013/14.  This decrease follows two years in which these 
percentages increased. 
                                                          
14
 https://gp-patient.co.uk/ 
15
http://gp-survey-
production.s3.amazonaws.com/archive/2014/July/1301375001_Y8W2%20National%20Summary%20Report_FINAL%20v1.
pdf 
16
 http://www.pssru.ac.uk/project-pages/unit-costs/2014/ 
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Table 27: GP activity by type 
  
GP 
Home 
visit 
GP 
Telephone 
GP 
Surgery 
GP 
Other 
Practice 
Nurse 
Other 
Clinicians 
Total 
2004/05 
Activity 5,800 12,500 148,300 4,200 84,600 10,200 265,600 
Cost 69 30 24 24 10 15 20 
2005/06 
Activity 6,000 14,000 153,900 4,800 93,700 10,700 283,100 
Cost 69 27 24 24 10 15 20 
2006/07 
Activity 5,900 15,100 156,600 5,000 99,000 11,400 293,000 
Cost 55 21 34 34 9 14 25 
2007/08 
Activity 5,900 16,200 155,800 4,800 98,500 11,300 292,500 
Cost 58 22 36 36 11 15 26 
2008/09 
Activity 6,000 18,700 158,800 5,500 100,600 10,800 300,400 
Cost 117 21 35 35 11 14 27 
2009/10(a) 
Activity 6,000 18,700 158,800 5,500 100,600 10,800 300,400 
Cost 120 22 36 36 12 17 28 
2010/11(a) 
Activity 5,844 18,212 154,659 5,357 97,977 10,518 292,567 
Cost 121 22 36 36 13 25 29 
2011/12(a) 
Activity 6,067 18,909 160,578 5,562 101,726 10,921 303,764 
Cost 110 26 43 43 14 25 33 
2012/13(a) 
Activity 6,160 19,200 163,047 5,647 103,290 11,089 308,433 
Cost 114 27 45 45 13 25 34 
2013/14(a) 
Activity 6,098 19,007 161,405 5,590 102,250 10,977 305,328 
Cost  114   28   46   46   14   25   35  
 
Survey data maintain the same target sample size over time.  Consequently, we adjust responses for 
population growth, estimates for which are available from the Office of National Statistics.
17
  
 
Quality indicators for primary care are taken from the Quality & Outcomes Framework (QOF), but in 
2013/14 there was a major restructuring of QOF codes and definitions
18
.  In previous years the 
following QOF indicators were used as our quality indicators: 
 
1. Coronary heart disease (CHD06)  
2. Stroke (Stroke06)  
3. Hypertension (BP05) 
These have now been changed to the following: 
 
1. CHD002 - The percentage of patients with coronary heart disease in whom the last blood 
pressure reading (measured in the preceding 12 months) is 150/90 mmHg or less (Threshold 
change and 15-12 month change) 
                                                          
17
http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-for-uk--england-and-wales--scotland-and-northern-
ireland/2013/sty-population-changes.html 
18
http://www.nhsemployers.org/~/media/Employers/Documents/Primary%20care%20contracts/QOF/2013-
14/Summary%20of%20QOF%20changes%20for%202013-14%20-%20England%20only.pdf 
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2. STIA003 - The percentage of patients with a history of stroke or TIA in whom the last blood 
pressure reading (measured in the preceding 12 months) is 150/90 mmHg or less (Minor 
wording change (noted in bold) AND 15-12 month change) 
3. HYP002 - The percentage of patients with hypertension in whom the last blood pressure 
reading (measured in the preceding 9 months) is 150/90 mmHg or less (Minor wording 
change, point and threshold change) 
Table 28: Quality adjustment for primary care 
 
Prevalence QOF achievement 
 
CHD Stroke Hypertension CHD Stroke Hypertension 
2004/05 3.57 1.63 10.41 78.60 73.13 64.33 
2005/06 3.57 1.66 11.48 84.44 81.22 71.05 
2006/07 3.54 1.61 12.49 88.86 86.92 77.62 
2007/08 3.50 1.63 12.79 89.41 87.51 78.35 
2008/09 3.47 1.66 13.13 89.68 87.88 78.56 
2009/10 3.44 1.68 13.35 89.77 88.12 78.72 
2010/11 3.40 1.71 13.52 90.16 88.57 79.30 
2011/12 3.38 1.74 13.63 90.14 88.61 79.65 
2012/13 3.40 1.70 13.68 90.57 89.26 80.79 
2013/14 3.29 1.72 13.73 92.27 89.84 83.09 
 
As the definitions of the indicators slightly changed, we can no longer compare like-for-like in our 
analysis, though the difference is not major.  
 
The numbers for prevalence are obtained from Annex 1 of the QOF report.
19
  Data about success 
rates are obtained from the clinical results tables, available in the same report. 
 
Growth in primary care consultations is reported in table 29. The survey data suggest that the 
number of primary care consultations decreased by 1.01% between 2012/13 and 2013/14.  Scaled 
up to account for the population growth, we get a slight positive growth of 0.27%. Finally after 
taking account of the quality of consultations, the growth in primary care consultations amounts 
to 0.37%. This is considerably lower than growth in preceding 2 years.  
  
                                                          
19
 http://www.hscic.gov.uk/catalogue/PUB12262 
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Table 29: Growth in primary care consultations 
 
Number of 
visits 
Population 
adjusted 
number of 
visits 
Population 
and quality 
adjusted 
number of 
visits 
Growth rate 
Population 
adjusted 
growth rate 
Population 
and quality 
and quality 
adjusted 
growth rate 
2004/05 265,600 265,600 274,122 
   
2005/06 283,100 283,100 295,289 6.59% 6.59% 7.15% 
2006/07 293,000 293,000 309,501 3.50% 3.50% 4.01% 
2007/08 292,500 292,500 311,375 -0.17% -0.17% -0.07% 
2008/09 300,400 300,400 322,662 2.70% 2.70% 2.79% 
2009/10 300,400 282,960 325,487 0.00% 2.82% 2.82% 
2010/11 292,567 305,435 319,456 -2.61% -1.11% -0.99% 
2011/12 303,764 319,661 334,468 3.83% 4.66% 4.70% 
2012/13 308,433 327,301 342,667 1.54% 2.39% 2.45% 
2013/14 305,328 328,199 343,942 -1.01% 0.27% 0.37% 
 
 
Figure 13: Number of visits in primary care 
 
3.6 Community prescribing 
Data about community prescribing are derived from the Prescription Cost Analysis (PCA) system, 
supplied by the Prescription Pricing Authority via the HSCIC Prescription Drugs Team.  The data are 
based on a full analysis of all prescriptions dispensed in the community, summarised into almost 
8,000 categories defined according to chemical composition.  The data include information about 
the Drug code (PropGenLinkCode), Net Ingredient Cost (NIC), Quantity of Drug Dispensed, and 
Number of Prescription Items. The data are complete and prices are available for all items across the 
years.  
 
Summary statistics about community prescribing are presented in Table 30. Drugs are categorised 
according to their chemical composition and the number of categories changes throughout the 
years, with the peak in 2004/05 (8,779 categories), falling to a low in 2013/14 (7,353 categories). 
 
The 2013/14 data contain information on 7,353 distinct community prescribed drug items 
representing over a billion prescriptions with a total value/cost of approximately £8.5 billion.  This 
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represents the first yearly increase in total nominal spend since 2010/11.  There are 340 new drug 
items totalling £0.75 million that appear in 2013/14 but not 2012/13.  On further inspection many of 
these new drugs are, in fact, low volume items that have appeared in years other than 2012/13 and 
have reappeared in 2013/14.  There are 690 drug items which appear in 2012/13 but not 2013/14, 
with a lagged total spend of £4.2 million.  There are 18 drugs for which the change in nominal spend 
is in excess of £10 million.   
 
There are no data items which appear obviously incorrect and we therefore take the data at face 
value. 
 
Table 30 Community prescribing, summary data 
Year 
Unique drug codes 
observed 
Total Px Total Spend (QtPt) 
Activity weighted 
average 
prescription unit 
cost (£) 
2004/05 8,779 691,948,868 £8,094,174,944 11.7 
2005/06 8,535 733,010,929 £8,013,483,226 10.93 
2006/07 8,218 762,631,738 £8,250,323,893 10.82 
2007/08 8,769 803,297,137 £8,303,500,918 10.34 
2008/09 8,276 852,482,281 £8,376,264,432 9.83 
2009/10 8,072 897,727,347 £8,621,421,130 9.6 
2010/11 7,860 936,743,859 £8,880,735,344 9.48 
2011/12 7,856 973,381,568 £8,777,964,802 9.02 
2012/13 7,699 1,001,825,994 £8,397,492,181 8.38 
2013/14 7,353 1,031,703,347 £8,540,423,964 8.28 
 
From the data we can observe changes in average cost of prescription and in unit (i.e. item) cost 
over recent years (Table 30).  Output and price indices for community prescribing are reported in 
Table 31.  Prices have fallen year-on-year over the whole period, the drop amounting to 1.45% 
between 2012/13 and 2013/14, a smaller decrease than that recorded in previous years.  The 
Laspeyres growth in the volume of prescriptions has increased annually, the most recent year-on-
year increase amounting to 3.20%, which is broadly average over the last three years. 
 
Table 31 Community prescribing: price and volume growth 
Year Paasche price ratio Laspeyres volume ratio 
04/05 to 05/06 0.9014 1.0984 
05/06 to 06/07 0.9659 1.0659 
06/07 to 07/08 0.9376 1.0735 
07/08 to 08/09 0.9485 1.0636 
08/09 to 09/10 0.9626 1.0693 
09/10 to 10/11 0.9833 1.0476 
10/11 to 11/12 0.9564 1.0335 
11/12 to 12/13 0.9282 1.0306 
12/13 to 13/14 0.9855 1.032 
 
Taking the base year as 2004/05, trends in the volume and prices of pharmaceuticals are shown in 
Figure 14. 
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Figure 14: Price and volume changes for community prescribed pharmaceuticals 
 
3.7 Output growth 
Output growth is measured by combining activities of different types into a single index, using costs 
to reflect their values.  This generates our cost-weighted output growth index, which increased by 
2.37% between 2012/13 and 2013/14.  
 
We then re-scale each type of cost-weighted output according to changes in survival rates, health 
improvements and waiting times.  This generates our quality-adjusted index, which increased by 
2.64% between 2012/13 and 2013/14.  
 
Table 32 Output growth 
Output growth 
All NHS 
Cost-weighted growth Quality adjusted CW growth 
2004/05-2005/06 6.53% 7.11% 
2005/06-2006/07 5.88% 6.50% 
2006/07-2007/08 3.41% 3.66% 
2007/08-2008/09 5.34% 5.73% 
2008/09-2009/10 3.44% 4.11% 
2009/10-2010/11 3.61% 4.57% 
2010/11-2011/12 2.38% 3.15% 
2011/12-2012/13 2.58% 2.34% 
2012/13-2013/14 2.37% 2.64% 
 
 Contribution by settings 3.7.1
Not all settings contribute equally to the output index. Figure 15 shows the share of overall spend 
for each of the settings as well as contribution to growth, calculated as share of overall spend 
multiply by the output growth of the setting.  More detailed information on contribution of each 
setting can be also found in table below.  
 
By far the largest contributor is HES activity, that has a share of 32.61% of totals spend and 33.16% 
of overall output growth.  Other sizeable contributors are primary care, Outpatient activity, 
community prescribing and community mental health.  All other settings contribute less than 6% to 
total spend or output. 
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Figure 15: Contribution by setting 
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Table 33 : Contribution of setting to Growth 
Setting Growth Qt-1Pt-1 Share of overall spend Contribution to growth 
All HES 1.67% 25,759,729,952 32.61% 33.16% 
Primary care  0.37% 11,589,721,226 14.67% 14.73% 
Outpatient 5.55% 8,454,528,207 10.70% 11.30% 
Community prescribing 
3.20% 8,397,492,181 
10.63% 10.97% 
Community mental Health -0.45% 6,289,108,108 7.96% 7.93% 
Community care  3.15% 3,942,970,966 4.99% 5.15% 
A&E 3.04% 3,692,014,018 4.67% 4.82% 
Specialised services 3.50% 2,927,444,066 3.71% 3.84% 
Chemo/Radiotheraphy/High cost Drugs 
9.29% 2,649,282,339 
3.35% 3.67% 
Opthamology & Dentistry 1.11% 1,814,682,950 2.30% 2.32% 
Diagnostic Tests 15.53% 941,490,357 1.19% 1.38% 
Radiology 7.50% 859,058,674 1.09% 1.17% 
Rehabilitation 12.13% 815,799,140 1.03% 1.16% 
Renal Dialysis 0.28% 528,076,698 0.67% 0.67% 
Other -5.50% 323,988,418 0.41% 0.39% 
          
    
78,985,387,300 
  
2.64% 
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4. Inputs 
Inputs into the health care system consist of: 
 
x Labour, such as doctors, nurses, technicians and managers; 
x Intermediate goods and services, such as drugs and clinical supplies; 
x Capital, such as buildings and equipment with an asset life of more than a year. 
 
We construct a comprehensive index of input growth, using the workforce data and organisational 
accounts submitted by NHS organisations.  These data are used to quantify the amount of all inputs 
used in the production of health care provided to NHS patients.  
 
Whereas we only have expenditure data for capital and intermediate inputs, labour data comes from 
two sources: expenditure data as well as staff numbers from the Electronic Staff Record (ESR).  We 
explore the consequences of using these alternative data sources about labour input.  We report 
estimates for two different formulations of the input index.  Our mixed index uses information about 
labour inputs recorded in the ESR; our indirect method uses expenditure data only.  
 
4.1 Direct labour  
Prior to 2007/08, we used data from the Workforce Census to count the number of staff working in 
the NHS.  But, since it was made available in 2007/08, we have used the ESR data to calculate growth 
in labour inputs.
20
  These data are obtained from the NHS iView database https://iview.ic.nhs.uk/ 
which draws data directly from the ESR, and combined Payroll and Human Resources system for the 
NHS.  The data contain numbers of full time equivalent (FTEs) staff and earnings by over 580 
different occupational groups for all staff employed in the NHS, by organisation.
21
  Where 5 or fewer 
staff members are employed in a particular staff group, the organisation randomly reports either 5 
or 0.  For this reason, the reported total number of staff constructed using the ESR source data 
differs from the aggregated figures published by the HSCIC.
22
  
 
Data on staff earnings come from a separate dataset, also provided by HSCIC, which includes all 
earnings data submitted by NHS organisations for staff paid directly by the NHS. This dataset 
contains average earnings by occupational group.  The following fields are available:
23
 
 
- Basic Pay Per FTE 12 Month 
- Total Earnings 12 Month 
- Basic Pay 12 Month 
- Non Basic Pay 12 Month 
 
In our calculation we sum together Basic Pay Per FTE 12 Month and non-basic pay to get total 
earnings for a particular staff group.  As non-basic pay is no longer reported by FTEs, but only by 
headcount, we multiply that number first by an FTE/headcount ratio to get the equivalent FTE 
number (as advised by HSCIC).  With the earnings information, we observe the change in associated 
cost by different occupational codes and organisation types. 
 
                                                          
20
 We excluded one organisation from the ESR data reported in 2011/12 that had not appeared in previous years. 
21
 We drop ESR reƚƵƌŶƐŵĂĚĞďǇƉƌŝǀĂƚĞƉƌŽǀŝĚĞƌƐ ?E,^ƌŵ ?Ɛ-length bodies, Special Health Authorities and other NHS bodies that report 
to the ESR but do not fall in the included categories (e.g. Sussex Health Informatics Service (YDD81) ) 
22
 https://iview.hscic.gov.uk/DomainInfo/WorkforceMonthly. Note that HSCIC does publish small numbers in some of their workforce 
data releases, for examples visit  http://www.hscic.gov.uk/catalogue/PUB13776/comp-of-neur-data-work_V2.xlsx 
23
 In the past we had information on total earnings per month, without separation in basic/non-basic 
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For three different occupational codes, we observe absolute changes in expenditure in excess of 
£50m between 2012/13 and 2013/14.  This is due to a substantial increase or decrease in the 
number of staff in these particular categories. 
 
Table 34: Occupational codes with large change in expenditure 
Occupational code Code description Change in #FTEs Change in expenditure 
N6A Other 1st level Acute, elderly & general 3,768 £162,416,637 
G2A Clerical & administrative Central functions (2,102) -£61,612,949 
H1A HCA Acute, elderly, general 2,573 £57,514,377 
 
Several new codes were adopted in 2013/14.  As stated in the NHS occupation codes guide,
24
 staff 
from the Major Staff Group (MSG) T (Scientific, Therapeutic and Technical Staff) is now reclassified 
into MSG U (Healthcare Scientists).  This reclassification happened towards the end of 2013/14: in 
2013/14, 3,456 people were classified under the U code and 35,616 under the T code.  For reporting 
purposes we merged both groups into one.  We do not have any information about earnings for staff 
in group U, and therefore imputed a value of average earnings for staff in MSG T.   
 
The number of organisations captured in the ESR changes every year (Table 35), not least due to the 
large NHS re-organisation.  There are additional changes due to the creation of new organisations, 
discontinuation of others, and mergers within existing categories.  However, the difference is also 
due to the increasing scope of organisations that report ESR data. 
  
Table 35 Number of reporting entities by organisation type 
Organisation type 2010/11 2011/12 2012/13 2013/14 
CCGs 0 0 9 152 
CSUs 0 0 0 24 
NHS England 0 0 1 1 
Non-geographical staff
a
 0 1 1 1 
PCTs 147 142 132 40 
SHA 10 10 10 2 
NHS Trusts 248 260 260 251 
a 
Non-Geographic Central Staff; code AHO 
 
Table 36 shows expenditure by organisational type as determined by the summed product of staff 
group FTEs and average earnings.  Table 36 also illustrates the impact that the NHS re-organisation 
has had on the apparent distribution of labour expenditure over time.  For example, in 2010/11, NHS 
Trusts accounted for approximately 83% of expenditure captured by the ESR.  In 2013/14, this had 
increased to approximately 97%.  This is due to the fact that the labour expenditure of PCTs and 
SHAs greatly exceeded the expenditure of the organisations that have replaced them: NHS England, 
the CCGs and CSUs.  
                                                          
24
 http://www.hscic.gov.uk/article/2268/NHS-Occupation-Codes 
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Table 36:  Expenditure on labour in current prices (£m) 
Organisation type 2010/11 2011/12 2012/13 2013/14 
CCGs £0 £0 £6.7 £433.5 
CSUs £0 £0 £0 £318.1 
NHS England £0 £0 £0.75 £221.4 
Non-geographical staff £0 £157.1 £142.6 £76.2 
PCTs £5,822.3 £3,742.2 £1,329.0 £89.2 
SHA £133.3 £113.7 £109.6 £0.4 
NHS Trusts £28,808.5 £31,761.3 £33,753.3 £34,509.6 
 
In part, this may be due to coverage issues that have arisen over the re-organisation.  For example, 
we know that there were 211 CCGs operating in 2013/14 but Table 35 shows that only 152 CCGs 
reported staff data in the ESR.  The inconsistent coverage over time raises some issues regarding the 
use of ESR as a measure of labour input.  For example, whilst not all trusts have used the ESR (e.g. 
Isle of Wight), it has previously been assumed that the growth in staffing observed by trusts within 
the ESR is representative of that in trusts not submitting ESR data.  However when there are new 
types of organisation altogether this assumption may be untenable. 
 
We are primarily concerned that the decrease in PCTs reporting between 2012/13 and 2013/14 may 
be a function of lower coverage as well as genuinely reduced labour input.  Conversely, the increases 
reported by CCGs may be a function of both a genuine increase and changing coverage over time.  
We note that the CCGs that reported data in 2013/14 tended to be larger (serving an almost 40% 
higher population on average), and with older populations on average, than those that did not 
report. 
 
The number of NHS staff, measured as Full Time Equivalents (FTEs), is reported in Table 37. Figure 16 
presented growth in labour input from a base of 2007/8.  Numbers of GPs and practice staff are 
taken from the Workforce Census.  The method used to count practice staff was revised in 2011/12, 
though the counts for both methods are available for this year.  We do not use the numbers of GPs 
and practice staff directly in our calculation of input growth but use expenditure data instead.  
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Table 37 NHS Staff numbers 
 
2004/5 2005/6 2006/7 2007/8 2008/9 
2009/ 
10 
2010/ 
11 
2011/ 
12 
2012/ 
13 
2013/14 
GPs (a) 31,021 32,855 33,384 33,730 34,043 36,085 35,243 35,319 35,871 36,294 
GP Practice staff  69,140 72,006 72,990 75,085 73,292 72,153 73,306    
GP Practice staff  W 
new method 
      82,802 84,609 85,546 87,114 
Medical staff (b) 78,462 82,568 85,975 84,811 90,460 93,393 95,531 99,331 100,878 100,797 
Ambulance staff    21,149 23,084 24,489 25,056 24,908 24,566 24,757 
Administration 
and Estates staff 
   237,264 243,018 262,479 263,723 250,539 242,980 239,359 
 
Health care 
assistants and 
other support 
staff 
   101,114 106,406 112,710 114,786 116,643 116,018 119,138 
 
   
    
   
Nursing, 
midwifery and 
health visiting 
staff and learners 
   366,520 372,132 379,841 380,114 377,948 363,781 369,246 
 
   
    
   
Scientific, 
therapeutic and 
technical staff 
and healthcare 
scientists 
   141,754 150,056 159,538 165,454 168,750 164,312 165,683 
 
Unknown and 
Non-funded staff 
   4,327 3,595 3,462 3,351 3,055 2,652 2,423 
 
Professionally 
qualified clinical 
staff 
412,013 425,044 425,983 
    
   
Support to clinical 
staff 
271,347 278,994 273,202 
    
   
NHS 
infrastructure 
support staff 
178,530 186,510 178,230 
    
   
 
   
    
   
 
   
    
   
Volume Index FTE  
3.60% -0.76% -0.37% 2.85% 4.39% 1.91% -0.43% -2.11% 0.72% 
Labour Index  3.44% 0.64% 0.64% 4.22% 4.55% 1.29% -0.24% -1.95% 0.38% 
Notes: (a) Data for GPs and GP practice staff is not available from ESR; Workforce Census data is used instead; there were also changes in counting 
of GP Practice staff therefore 2010/11 and 2011/12 years are not comparable to previous years. This includes GPs and GP trainees working in 
hospital http://www.hscic.gov.uk/media/9377/NHS-Occupation-Code-Manual-v10/pdf/NHS_Occupation_Code_Manual_Ver_10.pdf 
(b) FTE data prior to 2007/08 is taken from the Workforce Census data. FTE data from 2007/08 onwards is taken from organisational returns of 
Electronic Staff Records. When there are 5 or less people employed in an occupational group, organisations report either 5 or 0; these totals 
therefore will differ from those derived from national level data.  
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Figure 16: Growth in non-medical staff 
 
Table 38: Growth in direct labour 
Year 
Nominal Expenditure Growth Laspeyres Volume Growth 
All* Trusts All* Trusts 
2007/08 to 2008/09 7.61% 7.21% 4.14% 3.77% 
2008/09 to 2009/10 7.03% 6.55% 4.54% 4.15% 
2009/10 to 2010/11 2.62% 3.70% 1.42% 2.95% 
2010/11 to 2011/12 2.91% 10.25% 0.1% 7.26% 
2011/12 to 2012/13 -1.21% 6.27% -1.97% 5.5% 
2012/13 to 2013/14 0.87% 2.24% 0.38% 1.71% 
* all organisations reporting to ESR except independent providers; arms-length bodies and special health authorities 
 
Table 38 shows the growth in nominal expenditure and the Laspeyres input growth over time by 
trusts and by all included organisations (i.e. Trusts plus PCTs, CCGs, CSUs, NHS England, SHAs and the 
non-geographical category).  As expected, due to wage inflation, the Laspeyres input growth is 
always smaller than the nominal growth.  Of note, however, is the consistently positive growth in the 
trust setting and, in particular, the large growth from 2010/11 to 2012/13 despite austerity.  This has 
been attributed to the tƌĂŶƐĨĞƌŽĨWdƐƚĂĨĨƚŽƚƌƵƐƚƐǀŝĂƚŚĞ ‘dƌĂŶƐĨŽƌŵŝŶŐŽŵŵƵŶŝƚǇ^ĞƌǀŝĐĞƐ ?
initiative.
25
 
 
At 0.38%, the growth rate for labour in 2012/13  W 2013/14 is positive but relatively small.  A priori 
expectations may have been that this figure would be larger because of the impact on staffing levels 
in trusts following the Keogh and Berwick reports, CQC inspections and the Francis Inquiry, this 
dealing with poor level of care in the Mid Staffordshire Trust and advising that higher staffing ratios 
be adopted.  The impact of the various staffing and quality reports is thought to have impacted only 
on the last quarter of the financial year and, therefore, would only have a limited impact on annual 
labour resource use.  As shown in Figure 17, the number of staff started rising only several months 
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 https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/229996/Annual_Report.pdf  
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after the publication of the Francis report, the consequences of which may be more visible in 
2014/15. 
 
 
Figure 17: Changes in number of FTE in different categories by month 
 
4.2 Expenditure data 
The source of expenditure data has changed over time and by type of organisation, as summarised 
in Table 39. Data for Foundation Trusts are derived from the Consolidated NHS Financial Trust 
Accounts, the format of which has remained unchanged over the full period.  These accounts are 
less detailed than Trust Financial Returns (TFRs), which were reported by NHS trusts, PCTs and SHAs 
up to and including 2011/12.  These provided a detailed breakdown of expenditure on different 
types of NHS and agency staff, intermediate inputs and capital items. 
 
The TFRs were discontinued in 2011/12 for PCTs and SHAs.  For residual expenditure by these 
disbanding organisations we have relied on aggregated information as reported in the DH Annual 
Report and Accounts.  
 
For NHS Trusts, TFRs were replaced with Financial Monitoring and Accounts, although both reporting 
systems were used in 2011/12.  The Financial Monitoring and Accounts are much less detailed than 
the TFRs, reporting information for very broad categories of input type, making it no longer possible 
to report time series for specific input types. For instance, it is not possible to identify expenditure 
by NHS Trusts on agency staff from this information.
26
  Instead, we have used data provided by the 
Department of Health to identify recent expenditure on agency staff. 
  
                                                          
26
http://www.parliament.uk/business/publications/written-questions-answers-statements/written-
question/Commons/2014-10-22/211600/ 
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Table 39 Source of financial information 
 
2004/5-2011/12 2011/12-2012/13 2012/13-2013/14 
Foundation Trusts Consolidated NHS Financial Trusts Accounts 
NHS Trusts 
Trust Financial 
Returns 
Financial Monitoring and Accounts 
PCT/SHAs 
PCT/SHA Financial 
Returns 
DH Annual Reports and 
Accounts 
N/A 
NHS 
England/CSUs/CCGs 
N/A 
DH Annual Reports and 
Accounts 
 
Other than loss of detail, the more aggregated data has two major implications for the construction 
of the input index: 
 
1. Rather than input-specific price deflators, we now have to apply deflators for each 
aggregated input category.  This may generate inaccuracy in distinguishing the contributions 
of changes in volume and prices to expenditure growth. 
 
2. The detail in the financial returns made it possible to account for utilisation of different 
types of capital in each period, albeit subject to various assumptions about asset life and 
depreciation (Street and Ward, 2009).  The annual accounts, however, do not identify all 
items of capital.  This makes it impossible to ascertain how much has been spent on capital 
in each period, let alone how much of the capital acquired has been utilised. 
 
The financial reporting lines designated as intermediate and capital items in the most recent 
financial data are listed in Table 40 for NHS Trusts and PCTs/SHAs.  
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Table 40 Intermediate and capital items 
 Intermediates Capital 
NHS Trusts 
Source: 
Financial Monitoring 
& Accounts 
Services from Other NHS Trusts 
Services from PCTs 
Services from Other NHS Bodies 
Services from Foundation Trusts 
Purchase of Healthcare from Non-NHS 
Bodies 
Supplies & Services - Clinical 
Supplies & Services - General 
Consultancy Services 
Transport 
Audit fees 
Other Auditors Remuneration  
Clinical Negligence 
Research & Development (excluding 
staff costs) 
Education & Training 
Establishment 
Other 
 
Premises 
Impairments & Reversals of Receivables 
Inventories write downs 
Depreciation 
Amortisation 
Impairments & Reversals of Property, Plant 
& Equipment 
Impairments & Reversals of Intangible 
Assets 
Impairments & Reversals of Financial Assets 
Impairments & Reversals for Non Current 
Assets held for sale 
Impairments & Reversals for Investment 
Properties 
PCTs/SHAs/CCGs/NHS 
England Group 
Source:  
DH Annual Report & 
Accounts 
Consultancy Services 
Transport 
Clinical Negligence Costs 
Establishment 
Education, Training & Conferences 
Supplies & Services - Clinical 
Supplies & Services - General 
Inventories consumed 
Research & Development Expenditure 
Other 
Premises 
Impairment of Receivables 
Rentals under operating leases 
Depreciation 
Amortisation 
Impairments & reversals 
 
 Input use derived from expenditure data 4.2.1
Table 41 presents expenditure reported by PCTs, CCGs and NHS England Group. We can see that the 
expenditure by PCTs had a huge drop in 2011/12, due to reorganisation of the NHS and transfer of 
staff from PCTs to Trusts. PCTs officially ceased to exist in 2013/14; their activity was partly taken 
over by CCGs, as well as by CSUs (Commissioning Support Units) and NHS England, together forming 
the NHS England Group.  
 
It is not clear which activity was taken over by which organisation. Unlike PCTs CCGs do not perform 
clinical activity and is also unclear how other new organisations share the work previously done by 
PCTs and SHAs.  
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Table 41 Current expenditure by PCTs (£000), CCGs and NHS England Group 
 
Current Labour Intermediates Capital 
PCTs 2007/08 6,701,228 2,617,114 1,174,841 
2008/09 7,478,953 2,526,610 1,247,997 
2009/10 8,230,341 2,623,459 1,703,974 
2010/11 7,175,399 2,638,638 1,171,813 
2011/12 2,328,314 2,052,029 892,604 
2011/12* 2,358,373 860,860 1,721,795 
2012/13* 1,938,770 885,265 1,814,809 
CCGs 2013/14* 658,156 613,742 356,272 
NHS 
England 
Group 
2013/14* 1,529,067 1,522,637 667,386 
Note: * Data prior to 2011/12 from Financial Returns and from 2011/12 data from DH Annual Report and Accounts. 
Intermediate and capital items are identified differently in each source 
 
As we can see from Table 41 and from Table 42, expenditure from PCTs was much higher than 
expenditure by CCGs, or even by the whole NHS England Group.  
 
Table 42: Expenditure for PCTs, CCGs and NHS England Group 
 
 
Table 43 shows the expenditure for labour, intermediates and capital for trusts and foundation 
trusts.  We observe a steady increase across all the categories. In current terms, labour increased by 
3.6%.  We also observe large increases in expenditure for intermediates and capital, amounting to 
7.2% and 6.8% respectively.  
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Table 43 Current expenditure by NHS Trusts (£000) 
Current Labour Intermediates Capital 
2007/08 30,884,556 10,140,836 6,452,630 
2008/09 33,435,219 11,322,441 6,340,019 
2009/10 35,983,781 12,115,273 6,529,977 
2010/11 38,222,951 12,961,217 6,839,898 
2011/12 42,647,889 14,941,588 7,278,435 
2011/12* 42,701,684 17,477,370 12,097,485 
2012/13* 43,797,935 19,681,855 12,377,259 
2013/14* 45,360,562 21,108,612 13,217,703 
Note: * For NHS Trusts, data from prior to 2011/12 from Financial Returns and from 2011/12 data from Financial 
Monitoring and Accounts. Intermediate and capital items are identified differently in each source 
 
The use of agency staff is subject to considerable year-on-year variation, as shown in Figure 18.  The 
substantial increase of 23% between 2012/13 and 2013/14 will contribute to increased overall input 
growth. 
 
 
Figure 18: Trends in use of agency staff 
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Figure 19: Agency staff as a percentage of total staffing costs 
 
Table 44 presents current expenditures for the total NHS. In 2013/14 we do not include spend for 
DH admin.  This is due to the restructuring of the NHS and changes to the DH responsibilities. In 
order to compare like-with-like, we omitted this cost in both 2012/13 and 2013/14 in our 
calculations of input growth between these years. 
 
Table 44 Total NHS current expenditure (£000) 
Current NHS Staff Agency Intermediate Capital Prescribing 
Primary 
Care 
DH Admin TOTAL 
2004/05 31,334,252  1,557,282 8,757,990 5,115,514 8,094,175 9,569,836 278,000 64,707,050 
2005/06 33,926,746  1,459,936 10,271,344 5,839,664 8,013,483 11,162,141 262,000 70,935,314 
2006/07 35,177,509  1,185,244 11,378,727 6,568,363 8,250,324 11,209,422 229,000 73,998,589 
2007/08 36,561,167  1,207,654 13,036,200 7,784,592 8,303,501 11,697,639 226,000 78,816,753 
2008/09 39,264,185  1,895,423 13,991,803 7,426,031 8,376,264 12,074,672 242,958 83,271,336 
2009/10 42,104,673  2,302,578 14,911,074 7,635,390 8,621,421 12,683,418 241,608 88,500,162 
2010/11 43,513,839  2,127,889 16,077,609 8,025,361 8,880,735 12,962,081 212,245 91,799,759 
2011/12 43,360,622  1,872,598 17,221,673 8,265,079 8,777,965 13,250,874 453,000 93,201,811 
2011/12* 43,457,477  1,862,385 19,154,991 13,892,358 8,777,965 13,250,874 453,000 100,849,049 
2012/13* 43,654,591  2,345,552 21,442,537 14,273,017 8,397,492 13,419,803 457,000 103,989,992 
2013/14* 44,282,582 2,607,047 22,631,246 13,885,089 8,540,424 13,294,670 n/a
27 
105,241,061 
* For NHS Trusts, data from prior to 2011/12 from Financial Returns and from 2011/12 onwards data from Financial 
Monitoring and Accounts. Agency costs, intermediate and capital items are identified differently in each source 
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4.3 Input growth 
Our measures of input growth are reported in Table 45, differentiated according to the use of the 
mixed or indirect index.  Estimates of input growth have generally been higher if using the mixed 
rather than the indirect input index.  However, this is not the case for 2012/13  W 2013/14, where 
the mixed index suggests a growth rate of 0.43% while the indirect index suggests that input 
growth amounted to 0.55%.  This is because labour growth in the most recent pair of years appears 
lower if using data derived from the ESR instead of the accounts. 
 
Previously we have expressed a preference for the indirect measure, believing that direct 
measurement of labour input using workforce data is preferable to indirect measurement using 
expenditure data.  However, due to concerns about the coverage of CCGs in the ESR, labour inputs 
may be undercounted.  Consequently, the indirect measure may more closely capture growth in 
labour inputs in the most recent pair of years.  Reassuringly, though, the discrepancy between the 
two measures is small, with a difference of just 0.12%.  
 
Table 45 Input growth 
Input Growth All NHS 
Mixed Indirect 
2004/05  W 2005/06 7.19% 7.10% 
2005/06  W 2006/07 1.92% 1.36% 
2006/07  W 2007/08 3.88% 3.70% 
2007/08  W 2008/09 4.23% 4.24% 
2008/09  W 2009/10 5.43% 5.83% 
2009/10  W 2010/11 1.33% 0.80% 
2010/11  W 2011/12 1.00% 0.75% 
2011/12  W 2012/13 1.98% 2.63% 
2012/12  W 2013/14 0.43% 0.55% 
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5. Productivity growth 
Year-on-year quality adjusted productivity growth figures over the pair of years from 2004/05  W 
2013/14 are provided in Table 46.  We find that, if we use the mixed approach to capture input 
growth, productivity growth for the last three pairs of years has been positive, although the growth 
rate has been declining over time.  This conclusion is sensitive to how NHS staff inputs are 
measured: productivity growth for 2012/13  W 2013/14 is estimated to have been 2.20% based on 
the mixed method, and 2.07% if based on the indirect method.   
 
Table 46 Productivity growth year-on-year 
Productivity growth All NHS 
Mixed Indirect 
2004/05  W 2005/06 -0.07% 0.01% 
2005/06  W 2006/07 4.50% 5.07% 
2006/07  W 2007/08 -0.21% -0.04% 
2007/08  W 2008/09 1.44% 1.43% 
2008/09  W 2009/10 -1.25% -1.63% 
2009/10  W 2010/11 3.21% 3.74% 
2010/11  W 2011/12 2.13% 2.38% 
2011/12  W 2012/13 0.36% -0.28% 
2012/13  W 2013/14 2.20% 2.07% 
 
As can be observed in Figure 20, both input and output series seem to be on a downward trend, with 
apparent lags in latter.  Where the output line is above the input line the productivity growth is 
positive, in other cases it is negative.  
 
 
Figure 20: Input and output growth 
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Figure 21 present the input, output and productivity indices over time.  We can observe very slow 
growth in the input series which drives the productivity upwards.  
 
 
Figure 21 Trends in input, output and productivity growth 
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6. Conclusions 
Total NHS productivity growth between 2012/13 and 2013/14 was 2.20% under the 'mixed' method 
of calculation and 2.07% under the 'indirect' measure.  This represents a substantial rise on the 
0.36% and -0.28% estimates recorded for the previous pair of financial years, and is the fourth 
consecutive period of year-on-year growth. 
 
Quality adjusted output growth between 2012/13 and 2013/14 amounted to 2.64% for the NHS as a 
whole.  This value is similar to, but above, the 2011/12 to 2012/13 quality adjusted growth figure of 
2.34%.  In the overall series of output growth figures, from 2004/05 W2005/06 to 2012/13 W2013/14, 
it represents the second lowest output growth, and is lower than the average annual growth. 
  
The main setting in which output growth occurred was non-admitted patient care.  Non-admitted 
output growth as measured by reference costs is 3.70% and outpatient growth, as measured by HES, 
is 5.55%.  In comparison, inpatient output growth as measured by HES is only 1.67%.  There was a 
reduction in mental health activity: within the general category of HES measured inpatient output 
we note an inpatient mental activity growth of -5.36% and non-hospital growth of -0.45% 
 
Unlike 2011/12 W2012/13, the impact of quality adjustment in 2012/13  W 2013/14 has been to 
increase the measure of output growth.  This is due to decreasing waiting times and an 
improvement in survival rates per HRG between these two years.  For example, cost-weighted 
inpatient output growth is just 0.85%, but 1.67% when adjusted for quality improvements. Though 
the relative impact of quality adjustment may seem large, the absolute magnitude of the impact of 
quality adjustment is similar to previous years  
 
Our indirect measure of input growth indicates a growth of 0.55% and our mixed measure (using the 
direct measure of labour) is 0.43%.  Our usual base case measure uses the mixed method, as it 
generally recommended to use direct measures where possible.  However, concerns about the 
coverage of the Electronic Staff Record, used to populate our direct measure of labour and, 
specifically, probable incomplete coverage of the new CCGs suggests that it might be more accurate 
to measure labour input using expenditure data over 2012/13-2013/14.  Reassuringly, both 
measures of input growth are similar and there are no substantive differences between one or the 
other. 
 
Regardless of which measure is used, input growth is low and represents the lowest growth rate in 
our series.  The main reason for this has been the replacement of PCTs by the new organisations 
forming the NHS England Group (CCGs, CSUs, etc.)  For example, although not completely 
coterminous, CCG expenditure in 2013/14 was approximately 13% of PCT nominal expenditure in 
2008/09 (see table 40).  Even allowing for the steady decline in PCT expenditure  since the 
announcement of the planned reorganisation, the NHS England group expenditure in 2013/14 is still 
significantly below the equivalent organisational expenditure in 2012/13, with a negative growth 
measure of -21.25%.  Measurement of trust input growth, in contrast, remains relatively high, 
measured at 3.64%.  Perhaps surprisingly this is not attributable to labour growth motivated by the 
Francis Inquiry, Berwick and Keogh reports and CQC inspections, but more a function of growth in 
intermediates and capital expenditure. 
 
Overall, we estimate quality-adjusted productivity growth to be 2.07% using our indirect measure of 
input growth.  This is primarily a reflection of very low input growth generated by switching from 
relatively expensive PCTs (and SHAs) to a less resource intensive NHS England Group (predominantly 
CCGs).  The measure of productivity using our mixed measure of input growth is 2.20% but, as 
mentioned, probably represents an over-estimate due to incomplete coverage of CCG labour usage. 
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As usual, some caveats with our measurement exist, two of which are worth further note.  
 
Firstly, data on primary care are still problematic as there are no reliable comprehensive data 
sources for such data.  We continue to apply our standard approach of using survey data to estimate 
activity.  Whilst primary care represents a sizable component of output (approximately 14%) and is 
therefore an important component of the measurement, use of survey data does not have any 
obvious sources of bias that may over- or under-estimate our estimate.  As a result, it is difficult to 
predict what effect better primary-care data may have on our estimates.  
 
Secondly the large-scale reorganisation created by the 2012 Health and Social Care Act and the 
replacement of SHAs and PCTs by NHS England, CSUs and CCGs may have created some issues with 
measurement.   In particular, we have some reservations about the extent of coverage of both 
inputs and outputs for the outgoing and incoming organisations.  We strongly suspect, for example, 
that ESR coverage of CCG labour use is incomplete.  As a response to this, we have switched our 
preferred measure of input measurement for this particular report from mixed to indirect, as we 
believe the NHS accounts data have complete coverage.   
 
There may, however, also be issues on the output side which are less easily accommodated.  For 
example, there may have been some PCT activity in 2012/13 which is not recorded in reference 
costs.  If so, then the output measurement for 2012/13 would be under-estimated.  As PCTs did not 
officially exist in 2013/14, then any unrecorded output is likely to be less than in 2012/13  W i.e. if 
there is an issue of mismeasurement of PCT output, it is likely to be greater in 2012/13 than in 
2013/14.  The consequence of this would be an over-estimation of output growth between 2012/13 
and 2013/14.  However, whilst it is not possible to provide an alternative source of measurement as 
with the input data, we have no evidence to suggest that this is a particularly major issue.  For 
example, HES data, which should not have been affected, indicates very little PCT activity in 
2012/13.  Furthermore, the productivity measure for 2012/13 to 2013/14 is driven by very low 
growth in inputs, a measurement that we are confident is not biased by the re-organisation. 
 
In addition to our usual whole-NHS measurement we have also included a measurement for trusts 
only, which is contained in the appendix.  For trusts we find a quality-adjusted output growth of 
3.07% and a mixed method input growth of 3.60%, leading to a small but negative productivity 
growth of -0.51%. 
 
In conclusion, we find our preferred measurement of input and output growth for the whole NHS 
England Group for 2012/13 to 2013/14 to represent a fourth consecutive measure of positive 
productivity growth, and a fairly substantial increase from 2011/12 to 2012/13, where productivity 
growth was closer to zero.  As discussed, recent positive growth is partly a function of historically 
low output growth but mainly a reflection of low input growth due to the replacement of PCTs and 
SHAs by a less resource intensive NHS England Group. 
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8. Appendix 
In calculating productivity growth for the health care system, it is necessary to combine the 
multitude of outputs and inputs into single measures for both outputs and inputs.  This requires the 
construction of an output growth index (ܺ) and an input growth index (ܼ), with total factor 
productivity growth  ?ܶܨ  ܲcalculated by comparing growth in outputs with growth in inputs such 
that:  
  ?ܶܨܲ ൌሾܺȀܼሿ െ  ?           (1) 
 
In order to estimate total factor productivity, it is necessary to correctly define and measure the 
output and input indices. 
 
8.1 Output growth 
Quantification of health care output is a challenge because patients have varied health care 
requirements and receive very different packages of care.  To address this, it is necessary to classify 
patients into reasonably homogenous output groupings, such as Healthcare Resource Groups (HRGs) 
or Reference Cost (RC) categories.  Furthermore, in order to aggregate these diverse outputs into a 
single index, some means of assessing their relative value is required. Usually prices are used to 
assess value, but prices are not available for the vast majority of NHS services for which people do 
not have to pay at point of use.  In common with the treatment of other non-market sectors of the 
economy in the national accounts, costs are used to indicate the value of health services.  Costs 
reflect producer rather than consumer valuations of outputs, but have the advantage of being 
readily available. 
 
As costs are not believed to truly refleĐƚĐŽŶƐƵŵĞƌƐ ?ǀĂůƵĂƚŝŽŶƐ ?ƚŬŝŶƐŽŶƐƵŐŐĞƐƚƐƐƵƉƉůĞŵĞŶƚŝŶŐ
costs with information about the quality of non-market goods and services (Atkinson, 2010).  One 
way of doing this is by adding a scalar to the output index that captures changes over time in 
different dimensions of quality (Castelli et al., 2007).  Thus, following Castelli et al (2007), the output 
growth index (in its Laspeyres form) can be calculated across two time periods as: 
 
 ሺܺ଴ǡ௧ሻ௖௤ ൌ  ? ௫ೕ೟௖ೕబቈೡೕబ೜ೕ೟೜ೕబ ቉಻ೕసభ ? ௫ೕబ௖ೕబ಻ೕసభ      (2) 
 
We define j
x
 as the number of patients who have output type j, where jA? ? ?J; jtc  indicates the cost 
of output j; j
q
 represents a unit of quality for output j, and j
v
 is the value of this unit of quality; and 
t indicates time with 0 indicating the first period of the time series.  Our measures of quality include 
inpatient and outpatient waiting times, survival rates following hospitalisation, and blood pressure 
management in primary care.  
 
8.2 Input growth 
Turning to the input growth index (ܼ), inputs into the health care system consist of labour, 
intermediate goods and capital.  Growth in the use of these factors of production can be calculated 
directly or indirectly (OECD, 2001).  A direct measure of input growth can be calculated when data 
on the volume and price of inputs are available. In its Laspeyres form, the input growth index can be 
calculated as: 
 ܼሺ଴ǡ௧ሻ஽ ൌ  ? ௭೙೟ఠ೙బ೙ಿసభ ? ௭೙బఠ೙బ೙ಿసభ        (3) 
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Where nt
z
 is the volume of input of type n at time t and nt
Z
is the price of input type n at time t.  
 
However, data about the volume of inputs are rarely available.  It is, therefore, common practice to 
calculate input growth using expenditure data.  Changes in expenditure are driven by both changes 
in the volume of resource use and in prices.  Hence, to isolate the volume effect, it is necessary to 
wash out price chaŶŐĞƐďǇĐŽŶǀĞƌƚŝŶŐ ‘ĐƵƌƌĞŶƚ ?ŵŽŶĞƚĂƌǇǀĂůƵĞƐŝŶƚŽ ‘ĐŽŶƐƚĂŶƚ ?ĞǆƉĞŶĚŝƚƵƌĞƵƐŝŶŐĂ
deflator ߨ௡௧.  This deflator reflects the underlying trend in prices for the input in question, such that ߱௡௧ାଵ ൌ ߨ௡௧߱௡௧.  
 
If expenditure data and deflators are available, the input growth index can be specified as: 
 ܼሺ଴ǡ௧ሻூ௡ௗ ൌ  ? గ೙೟ா೙೟೙ಿసభ ? ா೙బ೙ಿసభ ൌ  ? ௭೙೟గ೙೟ఠ೙೟೙ಿసభ ? ௭೙బఠ೙బ೙ಿసభ ൌ  ? ௭೙೟ఠ೙బ೙ಿసభ ? ௭೙బఠ೙బ೙ಿసభ ൌ ܼሺ଴ǡ௧ሻ஽     (4) 
 
As shown, this is equivalent to using volume data, provided that deflators capture correctly the 
trend in prices for each input in question. 
 
8.3 Productivity growth 
The above equations show output or input growth over two periods from a base (0) to a current 
period (t).  Usually, there is interest in assessing productivity growth over longer periods of time. 
There are two ways to do this.  The first way is by means of a fixed base index, which applies the 
same set of output weights (cj) and input weights (ʘj), usually that of the base year (year 0), 
throughout the full series.  This has the advantage of using a common set of weights across all 
periods, allowing growth rates to be interpreted solely as changes in volumes.  Use of a fixed base 
index is common when calculating growth rates for a specified basket of goods and services. 
 
The drawback of this approach is that it requires the contents of the basket to remain unchanged 
over the full period.  If this requirement cannot be met, the alternative is to use a chained index.  
This approach has long been recommended (Lehr, 1885, Marshall, 1887) as a way to overcome the 
problems arising when new commodities appear and old commodities disappear, making the use of 
weights of the base year practically impossible.  By updating the weights in every period, it is 
possible to account for ongoing changes in the composition of the outputs and inputs being 
measured (Diewert et al., 2010). 
 
The main advantages of using a chained index, over a fixed base index, are: 
 
x ease of handling changes in the type of outputs produced and inputs utilised in production, 
as these only need to be common across two adjacent periods rather than for the full series 
(Balk, 2010); 
x regular updates of the weights better reflect actual price and volume changes (de Boer et al., 
1997); 
x the difference (or spread) between the Laspeyres and Paasche formulations of the indices is 
lower than it would be if using a base index. 
 
Using the Laspeyres output index as defined in eq. (2), a chained output index takes the following 
form: 
 
ሺܺ଴ǡ்ሻ௖௤ ൌ  ? ௫ೕ೟௖ೕబቈೡೕబ೜ೕ೟೜ೕబ ቉಻ೕసభ ? ௫ೕబ௖ೕబ಻ೕసభ  ൈ  ? ௫ೕ೟శభ௖ೕ೟ቈೡೕ೟೜ೕ೟శభ೜ೕ೟ ቉಻ೕసభ  ? ௫ೕ೟௖ೕ೟಻ೕసభ ൈ ? ? ?ൈ ? ௫ೕ೅௖ೕ೅షభቈೡೕ೅೜ೕ೅೜ೕ೅షభ ቉಻ೕసభ ? ௫ೕ೅షభ௖ೕ೅షభ಻ೕసభ  (5) 
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This can be simplified as: 
 ሺܺ଴ǡ்ሻ௖ǡ௤ ൌ ሺܺ଴ǡ௧ሻ௖ǡ௤ ൈ ሺܺ௧ǡ௧ାଵሻ௖ǡ௤ ൈ ? ? ?ൈ ܺሺ்ିଵǡ்ሻ௖ǡ௤         (6) 
 
where each link is represented by eq. (2) for the relevant two consecutive years.  An analogous 
construction applies to the chained input index. 
 
8.4 Note on quality adjustment 
As in previous years, we find a positive contribution of quality adjustment over time, even though 
the average value of the quality indicators might be falling.  This is mostly due to the shift of patients 
to more complex HRGs as well as to an ageing population.  
 
Shift of activity 
We can observe a shift of activity as an increasing number of patients is being treated in the more 
complicated HRGs.  The last letter in a particular HRG represents the split, which then accounts for 
potential complications and comorbidities (CC).  Splits are in alphabetical order, with A being the 
HRG with the most CCs. Letter Z means that no CCs present.  
 
In Table 47 we can observe the change to more severe splits between 2012/13 and 2013/14, 
ĐŚĂƌĂĐƚĞƌŝƐĞĚďǇŚŝŐŚĞƌƉĞƌĐĞŶƚĂŐĞŽĨĂĐƚŝǀŝƚǇŝŶƐƉůŝƚƐ ‘ ? ? ‘ ? ? ‘ ?ĂŶĚůŽǁĞƌƉĞƌĐĞŶƚĂŐĞŽĨĂĐƚŝǀŝƚǇŝŶ
other splits.  
 
Table 47: Percentage of CIPS in HRGs with different splits 
 
 
More complicated cases are correlated with lower survival rates and older population.  Although 
quality for these patients is improving, because more severe patients are being treated, average 
quality appears poorer.  We present an example of this in Table 48.  
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Table 48: Shift of activity; survival rates example for HRG EB10 
HRG #CIPS 2012/13 #CIPS 2013/14 Survival 12/13 Survival 13/14 
EB10A 1,073 2,306 71.95% 73.55% 
EB10B 4,267 5,485 77.83% 80.75% 
EB10C 9,671 9,389 85.13% 85.22% 
EB10D 17,328 13,302 94.25% 95.04% 
Average survival     88.62% 87.82% 
 
In this example, we observe a shift of activity towards more complicated cases (HRG ending with A is 
more complicated than B); survival rates improve in each HRG, but average survival falls. 
 
One way to see the impact of shift of activity on quality adjustment is to calculate the average 
impact of each indicator using the 12/13 distribution of patients across HRGs.  This can be seen in 
Table 49. 
 
Table 49: Shift of activity: relative contribution of each of the indicators using different distributions of HRGs 
 
2012/13 Distribution 2013/14 Distribution 
Waiting times 99.58% 100.06% 
Life expectancy 100.30% 100.65% 
30-day survival 99.65% 99.75% 
Total 99.84% 100.15% 
 
Ageing  population 
The shift of activity towards more complicated HRGs is closely linked with pressures associated with 
an ageing population and its influence on average life expectancy.  According to the tables produced 
by ONS, life expectancy is increasing every year. The example in the graph shows remaining life 
expectancy for children aged 0, 1 and 2 over time.  
 
Table 50: Life expectancy for children aged 0, 1 and 2 
 
 
According to ONS data and as illustrated in Table 50, if the age profile stayed the same over time, we 
would see an increase of average life expectancy.  However, this is not what our data shows. This is 
due to an increasing average age of population as can be seen in Table 51.  
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Table 51: Average age and average life expectancy 
 
 
Shift of patients to more complex HRGs as well as ageing population are the reason why the overall 
impact of quality on the output was positive in 2013/14, despite the apparent drop in achievement 
level for individual quality indicators.  Reported average values do not capture the quality 
improvement on the HRG level and we advise caution when using them for longitudinal comparison. 
 
8.5 Trust-only productivity measures 
While the main body of our text focuses on an overall NHS measure of productivity, we also produce 
estimates of Trust-only productivity changes, and the components thereof. 
 
The low growth in inputs, as captured in our NHS input index, may not fully reflect the actual state of 
this growth: due to reorganisation of the NHS and discontinuation of PCTs, we might not be able to 
fully capture life-for-like inputs data.  Therefore, we also calculate the inputs growth for trusts only, 
with the rationale being that their reporting is less affected by the changes.  As shown in Table 52 
the input index is much higher when taking only trusts into account, with a mixed index suggesting 
growth of 3.64% and indirect index growth of 3.60%.  
 
Similarly, we can also produce a trusts-only output index.  When we look at the activity performed 
by trusts only, the quality-adjusted output index rises to 3.07%, mainly due to a large increase in 
reference costs activity. 
 
Table 52: Input, output and productivity growth, trusts only 
 Input growth Output Growth Productivity growth 
Mixed Indirect  Mixed Indirect 
2012/13 W2013/14 3.64% 3.60% 3.07% -0.51% -0.54% 
 
Using this information we can produce trust-only productivity growth figures, estimated -0.51% 
(mixed measure) and -0.54% (indirect measure). These negative estimates of productivity growth 
for trusts are considerably lower than for the NHS as a whole.  
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